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Summary
The Hox genes encode a family of developmental regulators that are essential
for the normal patterning of the animal body axis. Their correct expression is con-
trolled by a number of mechanisms including RNA processing, a molecular system
that allows the formation of alternative mRNAs from a single gene. Previous work in
the Alonso Lab has demonstrated that RNA processing of the Drosophila Hox gene
Ultrabithorax (Ubx) by means of alternative splicing and alternative polyadenyla-
tion plays an important role during Drosophila development, but the mechanisms
underlying these regulatory processes are not well understood. In this project we
found that the Drosophila neural RNA binding protein ELAV has an important role
in the control of both Ubx alternative splicing and polyadenylation during embry-
onic development. Furthermore, by conducting a series of in vitro experiments we
demonstrate that ELAV is able to interact with two specific RNA elements located
within Ubx intronic sequences and mutation of such elements abolishes the interac-
tion. We also establish that embryos carrying a loss of function mutation in the elav
gene produce lower levels of Ubx mRNA and protein suggesting a role of ELAV on
Hox gene expression. Finally we investigated the roles that other Drosophila fac-
tors including RNA binding proteins, chromatin regulators and splicing regulatory
proteins may have on Ubx RNA processing and found several potential regulators.
All in all our work contributes to the understanding of the molecular basis of Hox
RNA processing control during Drosophila development.
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Chapter 1
Introduction
1.1 Control of gene expression
Gene expression is a very complex process that is highly controlled at several levels.
Spatial and temporal orchestration of the elements of gene expression is crucial for all
cellular processes, as well as growth, development and function of higher organisms
(Alonso and Wilkins, 2005), (Bhattacharjee et al., 2013).
During gene expression, genetic information flows from DNA to RNA through
transcription. Transcription requires the recognition of a promoter sequence (or
sequences) by factors and the transcription machinery in a sequence specific man-
ner (Bhattacharjee et al., 2013). The recognition of such sequence modules will
depend on the transcription factors and cofactors available at that time and in
that particular cell or tissue. At this level, chromatin remodelling also plays an
important and less understood role on overall transcription initiation. The spatial
structure and compaction of the DNA around nucleosomes dictates the accessibility
of a sequence elements to transcription factors (Alonso and Wilkins, 2005),(Jiang
and Pugh, 2009). Studies have revealed that the presence of nucleosomes is reduced
in intergenic DNA regions containing active promoters, potentially making them
more accessible to the transcription machinery. However, regions tightly packed in
nucleosomes can become accessible by the action of chromatin remodelling com-
plexes, such as the SWI/SNF complex (Orphanides and Reinberg, 2002), (Carey,
2005), (Jiang and Pugh, 2009), (Euskirchen et al., 2012), and references therein.
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1.2 Post-transcriptional gene regulation
The role of RNA is not just to transmit information, but to process it via several
biochemical reactions that modify its order and structure. Post-transcriptional gene
regulation refers to the processes at the RNA level and consist of mRNA of mod-
ifications such as the addition of the cap structure at the 5’ end of the transcript,
splicing, polyadenylation and editing that affects how this messenger is translated,
transported and degraded, giving as a result, an extremely finely spatial and tem-
poral regulated expression (Alonso and Wilkins, 2005), (Matlin et al., 2005), (Wang
and Burge, 2008), (Millevoi and Vagner, 2010), (Licatalosi and Darnell, 2010). In
this Introduction I will focus on splicing and polyadenylation only.
1.2.1 Splicing
Splicing is a posttranscriptional process where introns are removed from between
exons, which are ligated in one non-interrupted sequence suitable for translation.
When a pre-mRNA is just being transcribed, it contains exons separated by non
coding introns, which are delimited by splice sites. Introns are delimited by 5’
splice site (whose consensus sequence in mammals is AG-GU) and a 3’ splice site
(whose consensus sequence is AG-G). Introns also contain a conserved adenosine
which constitutes the branching point, needed for the splicing reaction, followed by
a conserved polypyrimidine tract. (Figure 1.1A). These sequences constitute the
core elements for splicing, which will be recognised by the core splicing machinery
(Jurica and Moore, 2003).
The splicing of an intron starts with the recognition of the 5’ splice site by U1
snRNP forming the complex E (Figure 1.1B). The 3 splice site, in turn, is recognised
by the subunit 35kDa from the U2AF complex (Matlin et al., 2005). SF1 splice factor
recognises the branching point forming the complex A. Complex B forms with the
addition of U2 snRNP and displacement of SF1. The catalytic complex is termed
C and promotes the 2 trans - esterification steps, the first one to produce the intron
lariat and the second one to join the exons together (Matlin et al., 2005). Auxiliary
cis and trans factors are also important for the control of splicing, particularly in
alternative splicing, explained below.
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Most of the cis elements playing a role in splicing choices are located within 150
nt of the splicing sites. This implies that distance from splicing sites is important
for the function of the element and it can be used to search for functional sites using
bioinformatic and biochemistry tools (Brooks et al., 2011).
Alternative splicing control
Transcripts can undergo alternative splicing (AS), where different exon inclusion
generates different isoforms from one single gene, increasing the number of 3’ and
5’ UTRs and possible proteins translated from it. Alternative splicing is a way of
generating transcript diversity by using optional exons and sections of exons, it is
important for the tissue specificity of gene expression and strikingly, more than 90
% of human genes undergo AS (Black, 2003), (Matlin et al., 2005), (Keren et al.,
2010), (Nilsen and Graveley, 2010).
Alternative splice sites often have weaker or non canonical splice sites that can
be selected by factors that can activate or inhibit them. Exon enhancers and si-
lencers or intron enhancers and silencers sequences aid in the process of controlling
alternative splicing (Figure 1.2A). These sequences are recognised by trans acting
factors such as SR proteins (arginine-serine-rich proteins) or hnRNPs, to enhance
or suppress the splicing of the alternative exon (Matlin et al., 2005), (Keren et al.,
2010). As a general rule, SR proteins serve as splicing activators, by facilitating the
recruitment of the splicing machinery whereas hnRNPs function as splicing repres-
sors (Shepard and Hertel, 2009), (Nilsen and Graveley, 2010). Figure 1.2B shows
two of the most common splicing types: cassette exon skipping (grey) and upstream
splice site (pink). Many of these factors have tissue specific expression, resulting in
a tissue specific control of alternative splicing. The combination of different factors
and different stoichiometries constitute a sort of cellular code, for RNA processing
control (Matlin et al., 2005).
1.2.2 3’ end processing
Another very important event in pre-mRNA processing is 3 end formation, which
is defined by the site of cleavage and polyadenylation of the 3’ UTR. Polyadeny-
lation consists in the cleavage and synthesis of an mRNA poly(A) tail by polyA
7
Figure 1.1: Basic mechanism of splicing. A) Representation of the core splicing
cis-elements signals showing the exons in blue boxes. The splice sites are shown in
the exon/intron junction, the branch point is marked by an arrow (red A) and the
polypyrimidine tract is marked in green. B) Sequence of spliceosome recruitment
and the formation of the intron lariat and binding of the exons. The 5’ SS is
first recognised by the U1 complex (E complex), next, the U2 complex binds the
branch point and circularises the RNA (A complex). U4/6 and U5 are recruited (B*
complex), then U1 and U4 are released to form the C complex, which catalyses the
two trans-esterification steps to form the intronic lariat and join together the exons.
5’ SS: 5’ splice site, 3’ SS: 3’ splice site. Figure modified from (Jurica and Moore,
2003).
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Figure 1.2: Alternative splicing. A) Position of cis elements that enhance or silence
the splicing of the alternative exon (gray), the blue and purple boxes represent
constitutive exons. The enhancing elements are represented with green bars whereas
the repressing elements are represented by red bars. Potential trans factors are
represented in blue ovals. B) The most common alternative splicing mechanisms.
Alternative exon is shown in gray, constitutive exons in brown and blue. Exon
skipping: The alternative exon is included when its 5’ and 3’ splicing sites are
recognised and is not included when its splicing sites are skipped. Intron retention:
the splicing machinery does not recognise the intronic splicing sites and the intron
is included in the mature RNA. Alternative promoter: an exon is not included if a
downstream promoter is used during transcription. Mutually exclusive exons: the
inclusion of the first exon blocks the inclusion of the downstream exon, whereas the
exclusion of the first exon allows the inclusion of the second. Alternative 5’ or 3’
SS selection: when a constitutive exon has two 5’ SS and the downstream is used,
a sequence is included in the exon; whereas the use of the upstream 3’ SS leads to
the inclusion of a fragment into the downstream exon. Alternative polyadenylation:
the presence of a Polyadenylation site within an intron leads to the loss of the
downstream exons. ISS: intronic splicing silencer, ESE: exonic splicing enhancer,
ESS: exonic splicing silencer, ISE: Intronic splicing enhancer, PAS: poly adenylation
site. Figure modified from (Jurica and Moore, 2003) and (Keren et al., 2010).
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polymerase (PAP) enzyme. Having such sequence helps in translation initiation
because it is recognised by the PABP that in turn binds the translation initiation
complex, circularising the mRNA and promoting ribosome recruitment and recy-
cling (Millevoi and Vagner, 2010). The polyA tail also protects the RNA from 3’
exonucleases and extends its half life. In turn, removing this tail is the first step
in degrading a transcript that is no longer needed (Bevilacqua et al., 2003),(Eulalio
et al., 2009), (Alonso, 2012). The polyadenylation signal in mammals, AAUAAA
(or the Proudfoot box) is one of the most conserved sequence elements known and
usually lies 10-30 bases upstream of the cleavage/polyadenylation site (Colgan and
Manley, 1997), (Proudfoot, 2011). A second element, a GU rich motif is 20-40 bases
downstream of the cleavage site, however, this element is less conserved. Both ele-
ments, their sequence and distance between them, determine the strength of the site.
The polyadenylation signal is recognised by the Cleavage and Polyadenylation Speci-
ficity Factor (CPSF) whereas the Cleavage stimulation Factor (CstF) enhances the
RNA/CPSF interaction by binding to the GU rich region. The PolyA polymerase
or PAP then adds up to 300 adenosines after cleavage of the RNA (Colgan and
Manley, 1997) (Figure 1.3A).
There may be several polyadenylation signals in an mRNA. The particular bal-
ance between trans factors recognising the different elements described above, will
determine which signal will be used and in turn, the 3’ end (Figure 1.3B) (Taka-
gaki et al., 1996). polyadenylation signals can be located at different positions of
the 3’ UTR or within introns, which when used, will lead to the elimination of the
exons downstream, changing the carboxyl end of the protein translated from that
message (Takagaki et al., 1996), (Soller and White, 2003), (Di Giammartino et al.,
2011), (Mueller et al., 2013). 3’ UTRs contain protein binding sites, miRNA target
sequences and might form secondary structures recognisable by other factors. This
information will direct the destiny of the mRNA in terms of stability, translation
or localisation. Thus, the same coding sequence could have different translation
or degradation rate, or even localisation if it has a different 3’ UTR (St Johnston,
2005), (Andreassi and Riccio, 2009), (Millevoi and Vagner, 2010), (Alonso, 2012).
RNA localisation allows the spacial control of protein translation within a cell,
important for many cellular processes such as cell signaling and polarization (An-
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dreassi and Riccio, 2009), (Martin and Ephrussi, 2009), (Jung et al., 2014), (Parton
et al., 2014). RNAs to be ”localised” are transcribed in the nucleus and coated with
proteins (forming mRNA-protein complexes) that will transport it and inhibit its
translation until it reaches its final destination, where translation is enabled (Holt
and Schuman, 2013). Translationally silenced RNAs can travel a considerable dis-
tance, for example in neurons, where they move from the nucleus to the axons or
dendrites. For example, the calcium/calmodulin-dependent protein kinase (CaMKII
alpha) and activity-regulated cytoskeleton-associated protein (arc) mRNAs are trans-
ported to dendrites as silenced RNAs in RNP granules by KIF5 (Kinesin Family)
along microtubules (Hirokawa et al., 2010).
Another example is the mechanism of Drosophila oocyte patterning that involves
the localisation of mRNAs such as nanos (nos), bicoid (bcd), gurken (gk), oskar (osk)
(Johnstone and Lasko, 2001). Drosophila bcd mRNA contains an 3’ UTR that forms
a complex secondary structure of multiple stem-loops which are involved in the RNA
localisation by staufen (stau) at bcd the anterior pole of the oocyte and early embryo.
Other factors participate in the transportation of the bcd mRNA serving as a link
to the microtubule network (swallow (swa) (Johnstone and Lasko, 2001).
Regulation of alternative polyadenylation
The selection of one or another polyadenylation site is often determined by the con-
centration of the general polyadenylation factors, for example, a strong PAS will
be used in low concentration factors whereas a weak site will be used only on high
concentration of factors (Millevoi, 2009), (Di Giammartino et al., 2011). Another
mechanism involved in PAS selection is provided by the presence of auxiliary factors
that are expressed often in a tissue specific manner. An example of this type of fac-
tor is NOVA (Licatalosi et al., 2008), (Di Giammartino et al., 2011). Genome-wide
High-throughput sequencing of RNA isolated by crosslinking immunoprecipitation
(HITS-CLIP) experiments using the human homologue of Pasilla (NOVA) revealed
numerous NOVA-RNA interaction sites in 3’ UTRs, in the vicinity of putative PAS
and when these sites were mutated, the general sites of polyadenylation were mod-
ified (Licatalosi et al., 2008). When NOVA binds close to the PAS (within 30 nt)
its role is inhibitory, presumably by interfering with the assembly of the polyadeny-
11
Figure 1.3: Polyadenylation and alternative polyadenylation. A) Position of cis
elements needed for polyadenylation showing the polyadenylation signal (PAS), the
auxiliary upstream element (AUE), the cleavage position (CA) and the auxiliary
downstream element (ADE). The arrows show the distance between the elements.
The trans elements are shown in ovals, dark blue for CPSF bound to the PAS, light
blue for CstF recognising the G/U rich sequence and the cleavage site recognised by
CFI, CFII and PAP. B) Figure modified from (Lutz, 2008).
lation machinery. When the NOVA binding site is further away from the PAS, it
stimulates the use of such site (Licatalosi et al., 2008), (Di Giammartino et al.,
2011).
Post-transcriptional RNA regulation by microRNAs
Another class of trans regulators involves small RNAs such as microRNAs (miR-
NAs). miRNAs are short dsRNAs that regulate the stability and translation of
mRNAs in a sequence specific manner (Ambros, 2003), (Huntzinger and Izaur-
ralde, 2011) (Fig 1.4). The mirRNAs are gene encoded but they are also found
within introns of other genes (He and Hannon, 2004). miRNAs are processed from
longer transcripts (pri-miRNAs) by the RNaseIII-like Drosha in the nucleus into
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pre-miRNAs of about 70 nt long and transported to the cytoplasm by Exportin-5
(He and Hannon, 2004) (Fig 1.4 A). Once in the cytoplasm, Dicer process the pre-
cursor hairpin (or pre-miRNA) further to an RNA duplex of about21-25 nt (Fig 1.4
B). The miRISC complex (miRNA Induced Silencing Complex) is loaded with the
miRNA containing strand, which is used to select the target mRNA by base-pair
interactions, retaining the target with partially or fully complementary sequence at
sites often within the 3’ UTR, but also found within the coding sequence and 5’
UTR (Huntzinger and Izaurralde, 2011). Most of the miRNAs studied so far show
a partially complementarity to its targets, leading to a reduction of the target pro-
tein production. This can be achieved by blocking the translation machinery or by
recruiting RNA degradation machinery (Fig 1.4 C). miRNAs or siRNAs (small in-
terference RNAs) having sequences fully complementary to their targets often cleave
their target mRNAs followed by RNA degradation by XRN1 and exosome RNases
(Fig 1.4 D).
miRNAs have important roles in very diverse biological functions including plant
and animal development, cell proliferation and differentiation, apoptosis and metabolism
(Ambros, 2003), (Kedde and Agami, 2008), (Jones and Newbury, 2010), (Huntzinger
and Izaurralde, 2011). For example, the bantam miRNA controls the expression of
the pro-apoptotic gene hid. Loss of bantam miRNA leads to up-regulation of hid,
causing slow growth of larvae and loss of imaginal discs (Jones and Newbury, 2010).
In this context, having a shorter or longer 3 UTR can regulate the amount and
type of cis elements regulating a given transcripts: having a longer 3’ UTR with
more miRNA binding sites may lead to more complex postranscriptional regulation
(Alonso, 2012). The Drosophila Hox geneUltrabithorax (Ubx ) provides a good ex-
ample of this mechanism. Ubx mRNA contains two functional PAS in its 3’ UTR.
The use of the proximal site produces a ’short’ UTR that is mostly present at early
embryonic stages. At later stages, however, the downstream second PAS is also
used, resulting in the production of a ”long” 3’ UTR which harbours many putative
miRNA binding sites. The production of the long 3’ UTR makes the transcript
”visible” or sensitive to miR-iab4/8 which leads to a reduction in Ubx mRNA levels
in the posterior segments of the Drosophila embryo (Thomsen et al., 2010).
AU-rich elements (AREs) are cis elements frequently present in 3’ UTR that me-
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Figure 1.4: microRNA biogenesis and mode of action. A) Although some are
encoded within introns from other genes, most microRNAs are transcribed by
RNApolII and are capped and polyadenylated (pri-miRNAs). The transcript form
secondary structures called hairpins, which are cropped by an RNaseIII enzyme
called Drosha (in red), resulting in pre-miRNAs of around 70 nt. The pre-miRNAs
are transported to the cytoplasm via Exportin-5 (in blue). B) Once in the cy-
toplasm, the pre-miRNA is processed by Dicer (in green) to produce the miRNA
duplex, of 21-25 nt. The RISC (RNA induced silencing complex, in yellow) is loaded
with the strand containing the miRNA sequence (in red) and is used to identify its
mRNA target. The target mRNA harbours microRNA target sites mainly within
the 3 UTR, but sometimes along the coding sequence or 5 UTR. C) When the
complementarity between the microRNA and target RNA is partial, showing com-
plementarity of at least the seed sequence (nucleotides 2-7 from the 5 end of the
miRNA) silencing of the target RNA can occur mainly through blocking translation
or recruiting RNA degradation machinery (CCR4/NOT deadenylases). D) In plants
and some cases in animals, miRNA have complete complementarity to their targets,
leading to the cleavage of the mRNA and subsequent degradation by the exosome
and XRN1 RNase. This mechanism has been used as a tool to repress specific mR-
NAs using artificial dsRNAs (or siRNAs). Figure modified from (He and Hannon,
2004), (Filipowicz et al., 2008) and (Huntzinger and Izaurralde, 2011).
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diate mRNA binding protein recognition for a diversity of functions. The most well
characterised known function is RNA degradation. In humans, the Tristetraprolin
protein binds an ARE element in the tumor necrosis factor-alpha mRNA and pro-
motes its deadenylation and degradation (Lai et al., 2005), (Barreau et al., 2005),
(Spasic et al., 2012). AREs can also prevent mRNA degradation mediated by the
HuR protein (Barreau et al., 2005), (Simone and Keene, 2013). mRNA localisation
is frequently mediated by cis elements within the 3’ UTR and the use of different
PAS can generate transcripts with or without localisation signals, radically affecting
the translation of such transcript (Colegrove-Otero et al., 2005), (Di Giammartino
et al., 2011).
The use of alternative polyadenylation sites is a widespread phenomenon so that
more than 50% of the human genes exhibit more than one polyadenylation iso-
form, and in many cases, these alternative isoforms are conserved in mouse (Di
Giammartino et al., 2011). Global studies have revealed that changes in polyadeny-
lation patterns can be related to cellular processes like proliferation and differentia-
tion. Cells in high proliferation, de-differentiation and in some cancers have general
UTR shortening whereas high differentiated cells (like neurons) and during late de-
velopment show a general lengthening of 3’ UTRs (Di Giammartino et al., 2011).
In summary, the establishment of the length of the 3’ UTR, by alternative
polyadenylation, determining its cis elements, is a crucial event that will shape
the expression of the gene (Alonso, 2012),(Merritt et al., 2008).
1.3 Crosstalk among RNA processing events
More and more evidence now suggests that mRNA processing events are highly
interconnected and coupled. (Smith and Valca´rcel, 2000), (Maniatis and Reed,
2002); (Licatalosi and Darnell, 2010). Each of these processing events is controlled
by the concerted action of a number of trans-acting factors that are present in
the cell in a tightly controlled stoichiometry. Furthermore, many of the sequence
elements can affect more than one RNA processing event, resulting in coordination
and interdependence of RNA processing events (Millevoi and Vagner, 2010).
A striking example is the coupling of transcription and mRNA splicing. It has
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been shown that transcription and splicing occur simultaneously (Goldstrohm et al.,
2001) and that RNApol-II transcription affects the splicing pattern of certain mR-
NAs as well as 3 end formation and mRNA export (Reed et al., 2010), (Millevoi and
Vagner, 2010).
RNApol-II has a central role in the coordination of mRNA processing, where
its carboxy-terminal domain (CTD) is key (Steinmetz, 1997), (Shukla and Ober-
doerffer, 2012). Some components of the splicing and polyadenylation machinery
are able to physically interact with the CTD, making them available immediately
during transcription. This plataform may facilitate the interaction between factors
afecting different aspects of RNA processing and distant sequences within the tran-
script. The CTD consists on a repeated sequence of amino acids (YSPTSPS) that
can extend up to 50 repetitions. Each unit can be dynamically phosphorylated giv-
ing it differential properties. The phosphorylated form has a higher negative charge
that might facilitate the interaction and binding of SR proteins and spliceosome
components, and actually splicing is enhanced when the CTD is phosphorylated
(Steinmetz, 1997). Likewise, two of the core components of the polyadenylation
machinery, the CPSF and the CstF (Steinmetz, 1997) interact directly with the
CTD to regulate 3’ end processing (Phatnani and Greenleaf, 2006). CPSF in turn,
interacts with the transcription factor TFIID (Di Giammartino et al., 2011). In hu-
mans, histone modification enzymes also can affect splicing, where histone markers
facilitate the recognition of splicing cis-elements, for example, the H3acetyl mark is
recognised by the acetyltransferase GCN5 which helps to recruit U2 snRNP, facili-
tating intron recognition (Hnilicova´ et al., 2011), (Luco et al., 2011), (Enroth et al.,
2012).
Another model for RNApol-II effect on splicing and particularly alternative splic-
ing is a kinetic model (de la Mata et al., 2003). In this model, when transcription
is slow, there is enough time for the recruitment of factors that might recognise
weak splice sites, promoting their use, thus enhancing exon inclusion. When tran-
scription is faster, stronger sites are preferably recognised, which enhances exon
skipping (Batsche´ et al., 2006). This model works on the assumption that tran-
scription and splicing occurs simultaneously. However, not all splicing events are
co-transcriptional an data suggests that introns located towards the 3’ end of the
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transcript, are more frequently spliced after transcription has finished (Kornblihtt
et al., 2004).
The rate of transcription of the RNApol-II can be affected by recruitment of
factors that affect polymerase II speed. The Brahma protein is a component of
the SWI/SNF chromatin remodelling complex making genes more accessible for
RNApol-II, potentially enhancing its processivity. The SWI/SNF complex has also
a role in transcription elongation, having direct contacts with the transcription ma-
chinery and with spliceosome components. Brahma, however, has a chromatin in-
dependent role in slowing the RNApol-II during transcription elongation allowing
exon inclusion (Batsche´ et al., 2006), (Luco et al., 2011).
The speed of RNApol-II also affects 3’ end formation. In the polo transcript, a
slow elongating polymerase allows enough time for the assembly of the polyadeny-
lation machinery in the first PAS, facilitating its use whereas a fast polymerase
would transcribe fast enough to expose both PAS to the polyadenylation machinery,
promoting the use of distal PAS (Pinto et al., 2011).
All of these lines of evidence points to a central role of RNApol-II in controling
and modulating almost every aspect of pre-RNA processing, from transcription to
splicing and 3’ end formation. It is likely that the polymerase functions as a platform
for the factors that will model the RNA processing within the very packed and
complex cellular environment, saving time and energy and avoiding mistakes.
Some protein factors also link mRNA processing events independently of RNApol-
II. For example, several splicing factors also interact with the polyadenylation ma-
chinery providing a link between splicing and polyadenylation: U2AF65 recognises
and binds the polypyrimidine tract of the last intron and recruits the CFI com-
plex promoting the use of the nearest PAS (Millevoi, 2009) (Millevoi and Vagner,
2010),(Di Giammartino et al., 2011).
1.4 RNA processing during development
During the embryonic development of higher eukaryotes, gene expression and RNA
processing are highly dynamic and controlled. Trans acting factors including RNA
binding proteins (RBP), play a key role in this process. RBPs are involved in every
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stage of gene transcription, processing, translation and degradation (Gamberi et al.,
2006).
RBPs are proteins that often contain a domain for RNA interaction, such as
RNA Recognition Motif (RRM), hnR NPK Homology (KH) domain (Gamberi et al.,
2006).
RBPs are important in the control of processing of transcripts during cell dif-
ferentiation and many of them are tissue specific, (Kalsotra and Cooper, 2011),
(Taliaferro et al., 2011). The result of this control is the establishment of regula-
tory networks that control specific cellular functions, differentiation or development
(Kalsotra and Cooper, 2011). For example, during the transition of mouse pluripo-
tent embryonic stem cells to embryoid body, near 100 alternative splicing events
occur (Salomonis et al., 2010). Some of these alternative splicing events modify im-
portant domains of proteins involved in the maintenance of pluripotency, progression
of the cell cycle and lineage specification (Salomonis et al., 2010). For example, the
human Forkhead box (FOX) transcription factor 1 is important in the establish-
ment of cell types of cardiomyocites during heart development (Zhang et al., 2010).
During cell differentiation, a cassette exon shows increased inclusion wich modifies
the FOX1 DNA binding specificity (Gabut et al., 2011).
Genome-wide studies have revealed that most of the transcripts in Drosophila ex-
perience alternative polyadenylation and that there are tissue-specific trends (Smib-
ert et al., 2012). For example, a general shortening of 3’ UTRs is observed in testis
and a general lengthening in the nervous tissue (Smibert et al., 2012). Other studies
have demonstrated that global 3’ UTR shortening is associated with cellular prolifer-
ation, which may be mediated by increased levels of the polyadenylation machinery
(Elkon et al., 2012). In several mammalian cancers, where the generation of shorter
3’ UTRs leads to the loss of micro-RNA regulatory sequences, there is increased
mRNA stability and increased protein production (Flynt and Lai, 2008), (Mayr and
Bartel, 2009), (Bava et al., 2013), (Li and Lu, 2013). For example, the 3’ UTR of
the human transcription factor MYB contains conserved miR-15a/16 and miR-150
target sites. The loss of its 3’ UTR leads to overexpression and protein production
of MYB (Persson et al., 2009).
The nervous tissue is a complex system that requires precise control of gene ex-
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pression to allow proper cell differentiation, neuron morphology and wiring of neu-
ronal circuits (Norris and Calarco, 2012). To achieve this, neuronal transcriptome
is enriched with regulatory motifs and trans-acting factors that regulate transcrip-
tion and post transcriptional processing generating a very high molecular diversity
(Norris and Calarco, 2012).
In neuronal tissue, alternative splicing events can control the presence or absence
of protein domains, this allows the control of the presence or position of protein in-
teraction surfaces, allowing the formation of protein complexes of diverse functions.
Human neuronal specific cassette exons have been identified in many proteins im-
portant for endocytosis functions (Ellis et al., 2012).
Understanding how mRNA processing is regulated during development sheds
light on the understanding how different developmental pathways are controlled in
a dynamic context. Recent studies have demonstrated that global mRNA polyadeny-
lation pattern changes with developmental progression. This has been demonstrated
in mouse embryos where mouse genes tend to express mRNAs with longer 3 UTRs
as embryonic development progresses (Ji et al., 2009).
1.4.1 Elav/HuR family
Some proteins can affect both alternative splicing and alternative polyadenylation,
however, little is known about the molecular mechanism mediating the crosstalk be-
tween different RNA processing events. A protein factor proved to affect alternative
splicing and polyadenylation is the Elav protein (embryonic lethal abnormal vision)
(Yao and Samson, 1992), (Sakai et al., 1994), (Koushika et al., 1996). The elav gene
is located in the X chromosome and produces a 50 kD protein of 483 amino acids
that contains an A/Q rich amino terminal region and three RRMs (RNA recognition
motif). The elav transcript contains two introns and three exons, one of the introns
is located in the 5’ UTR (Yao and White, 1991), (Yao and Samson, 1992). Elav
protein was the first neural-specific RBP described in Drosophila melanogaster and
expressed in the nucleus of post-mitotic neurons throughout all Drosophila stages
(Figure 1. 5).
In humans, there are four Elav-like proteins, HuR (human antigen R) (the most
similar to Elav), HuB, HuC and HuD. HuR is ubiquitously expressed whereas HuB,
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C and D are expressed solely in the CNS. HuR proteins have been described to
bind AREs via RRM domains. Elav-like proteins contain 3 RRM which are very
conserved (Antic and Keene, 1997), (Pascale and Govoni, 2012).
In humans, HuR proteins are able to increase the stability of their target mRNA
in the cytoplasm, although in some cases, they are able to decrease their translation
(Pascale and Govoni, 2012). HuD also plays a role in translation initiation, as a
protein needed in mRNA circularisation (Fukao et al., 2009). The third RRM do-
main has polyA binding activity whereas the hinge region recognises eIF4A protein,
helping in the circularisation of the mRNA. However, it is unclear how widespread
this role in translation is (Fukao et al., 2009).
Other two members of this family in Drosophila have been described: RBP9
and FNE (found in neurons). RBP9 shares 52% identity with Elav whereas FNE
shares 61%. RBP9 is expressed in neurons after mid-pupal stages and in oocytes
but not in embryonic stages (Yao and Samson, 1992), (Samson and Chalvet, 2003).
FNE has a similar expression pattern to Elav, although its expression in embryos is
delayed, and FNE protein is present in the cytoplasm. Interestingly, FNE and RBP9
interact (Samson and Chalvet, 2003). Elav protein has served as a very important
marker in the study of the Drosophila nervous system and differentiation of neurons
during development. However, little is known about the role of the Elav protein
itself in neuron determination and survival. Indeed, this work together with that of
colleagues in the the Alonso Lab and our collaborators at the University of Mainz
adds to this open question (see below).
During Drosophila embryonic CNS development, some neurons project their ax-
ons across the midline and contact their targets in the other side (Marillat et al.,
2004). These axons are called ”commissural” axons. Elav is important in directing
these axons to cross the midline and form ”commissures”. elav mutant embryos
have morphological defects in the nervous tissue, the commissures are thinner and
their pattern seems affected, particularly towards the posterior region. (Jimenez
and Campos-Ortega, 1987), (Simionato et al., 2007). The elav mutant does not in-
duce cell death but affects the ability of the axons to extend and cross the midline.
Neurons differentiate normally but the axonal projections are not directed properly.
A closer study of the molecular mechanisms for this shows that Elav interacts with
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Figure 1.5: Elav protein structure and expression. A) Elav protein domain organi-
sation, amino terminal A/Q rich domain and the three RRM domains, of which the
last one is separated by a hinge. The RRM1 and 2 bind A/U rich RNA, and in
humans the third RRM interacts with the polyA whereas the hinge interacts with
eIF4A, promoting mRNA circularisation and translation. The numbers represent
the aminoacid position in Drosophila (above) and Human (below). B) Elav im-
munostaining showing protein expression at embryonic stage 15 and CNS at larval
stage 3. A, anterior. P, posterior. C) Aminoacid alignment of Drosophila elav,
RBP9, FNE and human HuR proteins. Boxes indicate the RRM domains.
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the mRNA of commisureless (comm), which is a member of the Robo/Slit signalling
pathway that guides axons to cross the midline (Marillat et al., 2004), (Simionato
et al., 2007). comm mRNA and protein levels are reduced in the elav mutant. How-
ever, the precise molecular mechanism of Elav controling comm mRNA is unclear.
Other studies trying to elucidate the molecular function of Elav, have shown that
it is involved mainly in post transcriptional processing, particularly splicing and
polyadenylation of armadillo (arm), Neuroglian (ng), erect wing (ewg) and itself
(Borgeson and Samson, 2005), (Soller et al., 2008), (Soller et al., 2010).
armadillo encodes the Drosophila homolog of the vertebrate beta catenin, which
is an adhesion molecule and transcriptional regulator of Wnt/wingless pathway. Elav
stimulates inclusion of exon 6 resulting in a neuronal specific arm mRNA isoform
(Loureiro and Peifer, 1998), (Koushika et al., 2000), (Soller et al., 2008).
Neuroglian (ng)is a gene that encodes two protein isoforms by alternative splic-
ing, an ubiquitously expressed 167 kDa peptide and a neuronal 180 kDa one. The
presence of Elav in neuronal cells directs the production of the neuronal isoform.
Ectopic expression of Elav produces the neuronal isoform of ng (Koushika et al.,
1996), (Koushika et al., 2000). Elav binds a U-rich region in the last intron, either
affecting splicing directly or preventing the use of the closely located PAS (Lisbin
et al., 2001).
The best characterised Elav regulated mRNA processing event is the erect wing
(ewg) mRNA, which is a neuronal transcription factor involved in CNS develop-
ment and formation of flight related musculature (Fleming et al., 1983), (Koushika
et al., 1999). ewg mRNA is ubiquitously transcribed and undergoes alternative pro-
cessing in a tissue-specific manner. The neuronal isoform is polyadenylated in the
downstream polyadenylation sites located in the 3’ UTR (Arrows in Figure 1.6A).
This transcript leads to full length active protein (Koushika et al., 1999). How-
ever, the non-neural mRNA isoforms are polyadenylated within intron 6, loosing
the downstream exon (Figure 1.6A). The transcripts lacking the last coding exon
are not translated into proteins. Elav has been demonstrated to be the responsible
factor directing the use of the polyadenylation site located within the 3’ UTR and in
turn, promoting the retention of the last exon (Soller and White, 2003), (Soller and
White, 2005) (Figure 1.6B). The Ewg protein is a key transcription factor during
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Figure 1.6: ewg polyadenylation is regulated by Elav. A) Exon and intron organi-
sation of the ewg transcript, grey boxes represent non coding exons and black boxes
represent coding exons. Arrows mark polyadenylation sites (pA). B) Model of the
mechanism of Elav role in ewg polyarenylation site choice, binding directly as a
multimer to a sequence downstream pA2, interacting with CstF to block cleavage
on this site. Figure taken from (Soller and White, 2003).
the development of the Drosphila CNS and EWG protrein expression is sufficient
to rescue an elav mutant. This suggests that ewg is a major direct target of Elav
(Haussmann et al., 2008).
Elav also regulates polyadenylation site selection of its own mRNA. A screen
using a modified protocol of in vitro selection found several Elav binding sites, the
strongest of which maps to a non coding exon in the 3’ end of elav mRNA (Borgeson
and Samson, 2005).
RNA-seq studies have demonstrated that after the maternal-to-zygotic transition
(MZT) in Drosophila Elav coordinates the the use of more distal polyadenylation
sites of a set of genes in the CNS, generating transcripts with longer 3’ UTR (Hilgers
et al., 2011), (Hilgers et al., 2012), (Smibert et al., 2012). Not all of these transcripts
are neuronal, but the observed lengthening of 3’UTRs is restricted to the CNS
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and there is a high proportion of RNA binding proteins displaying longer UTRs
(Smibert et al., 2012). Interestingly, some of them show a sequential lengthening of
the 3’UTRs, presumably using a more distal polyadenylation site as development
progresses (Hilgers et al., 2011). elav transcript itself shows this behavior along
with fne, Brain tumor (brat), mei-P26 and argonaute1 (ago1). These long 3’ UTRs
are enriched in regulatory elements, compared to the corresponding short sequences,
including miRNA binding sites, polyadenylation signals and protein binding sites,
presumably for a more complex regulation during CNS development. However, the
effect on protein production have not yet been studied (Hilgers et al., 2011), (Smibert
et al., 2012). Elav ectopic expression is sufficient to promote the lengthening of the
3’ UTR outside neuronal tissue (Hilgers et al., 2012). RNA-IP experiments revealed
that Elav binds sites near polyadenylation signals, suggesting that Elav acts in a
similar way to the mechanism described in the ewg transcript (Soller and White,
2003), (Hilgers et al., 2012).
Ubx and other HOX genes also undergo 3’ lengthening at late stages of develop-
ment (Thomsen et al., 2010) but the mechanism for this remains unknown.
In ewg and neuroglian mRNA, the effect of Elav on alternative splicing and
polyadenylation come together because Elav influences polyadenylation site selection
between a proximal (within intron 6) and distal site (within 3’ UTR). In the absence
of Elav, the intronic PAS is used, so the polyadenylation process cleaves the RNA
within the intron, losing the downstream coding exon. When Elav is present, the
PAS in the intron is blocked, promoting the use of a downstream PAS located in the
3’ UTR and in consequence, the last coding exon is retained. However, Elav also
affects splicing independently of polyadenylation, as described for other mRNAS,
for example, in the armadillo (Koushika et al., 2000) and fas mRNAs (Izquierdo,
2010).
It remains unclear the mechanisms by which Elav can affect both splicing and
polyadenylation in the same transcript when the PAS sites are within the 3’ UTR
and not in an intron.
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1.5 Hox genes
During Drosophila embryonic development, a key event is the determination of seg-
ment identities along the body axis. This allows the development of body structures
in their correct position. One gene family involved in this process is represented by
the Hox genes (Figure 1.7). The Hox genes encode evolutionary conserved transcrip-
tional regulators that trigger different developmental programs at specific spatial
coordinates along the antero-posterior body axis of animals (McGinnis and Krum-
lauf, 1992), (Alonso, 2002). In Drosophila, the Hox genes have a peculiar orderly
arrangement along chromosome 3 that shows a strong correlation (termed colinear-
ity) with the order of expression within the Drosophila body axis (Hueber et al.,
2010) (Figure 1.7).
Mutations affecting Hox gene activity often result in major morphological alter-
ations; for example homeotic transformations observed in Drosophila i.e. Antenna-
pedia and Bithorax phenotypes(Garcia-Bellido et al., 1976), (Lewis, 1978), (Hughes
and Kaufman, 2002) (Figure 1.8). In spite of their general importance, many as-
pects of Hox gene function remain unclear. At early stages of Drosophila embryonic
development, cells within each segment acquire positional information by the combi-
nation of the expression of several genes deployed in a cascade. These genes encode
for transcription factors and are expressed in the following order: maternal, gap
and pair-rule. At this stage, the embryo is divided in 14 segments. The Hox genes
are expressed depending on the relative expression of those genes along the AP axis
and then they direct the morphogenetic complexity within each segment (Maeda
and Karch, 2006), (Lewis, 1978). However, it is not clear how Hox gene activity
is regulated at the cellular level during the progressive development of segments.
Regulation of Hox gene transcriptional patterns, RNA processing and microRNA
contribute to the establishment of segmental cellular identity (Bender et al., 1983)
(Ronshaugen et al., 2005), (Bushati et al., 2008), (Bender, 2008).
It has recently been shown that alternative splicing (AS) plays an important
role in Hox specificity. Specific splice isoforms of the Drosophila Hox gene Ubx have
distinct DNA binding specificities. The different isoforms activate transcription
with different efficiency genes in the embryonic mesoderm and have different ways
to pattern muscles in Drosophila embryos (Reed et al., 2010), (de Navas et al., 2011)
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Figure 1.7: The Hox genes. A) Drosophila embryo showing body segments, the
colours represent the domains of expression of the different hox genes, shown in C. B)
Drosophila adult showing the expression domains of Hox genes. C) Representation
of the chromosomal position of the Hox genes. lab: labial, pb: proboscipedia, Dfd:
deformed, Scr: sex combs reduced, Ant: antennapedia, Ubx : Ultrabithorax, abd-A:
abdominal-A, abd-B: abdominal B. Figures taken from (Hueber et al., 2010).
(Figure 1.8).
1.5.1 Ultrabithorax
Drosophila Ubx protein is a transcription factor and is the product of one of the
three Hox genes in the bithorax complex. Ubx guides the development of embryonic
parasegments 5 and 6, which correspond to the third thoracic and first abdominal
segments (Akam and Martinez-arias, 1985), (White and Wilcox, 1985) (Figure 1.8B).
During adult Drosophila development Ubx controls the differences between wings
and halteres (the small dorsal appendages in the posterior thorax) (Garcia-Bellido
et al., 1976), (Lewis, 1978). Ubx protein is expressed in the haltere throughout
development (White and Wilcox, 1985) and its absence leads to a complete homeotic
transformation of the haltere into a wing (Figure 1.8C) (Bender et al., 1983). The
Ubx protein is also responsible for the patterning of segments within musculature
and the central nervous system (CNS) (Kornfeld et al., 1989) and it is expressed in
the CNS, mesoderm and epidermis at late embryonic stages (Figure 1.8B).
The Ubx transcript produces several protein isoforms through AS which differ
from one another by the presence of the two optional microexons (mI and mII)
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Figure 1.8: The Ultrabithorax gene. A) Representation of the Ubx gene. Boxes rep-
resent coding exons, constitutive exons in blue, microexons I and II in red and green
respectively. Gray bars represent 5’ and 3’ UTRs and lines represent introns. The
numbers represent the sizes of each element in bp. Arrowheads represent the sites of
polyadenylation. B) Enzimatic anti-Ubx immunostaining at stage 12 and 16 of em-
bryonic development showing high Ubx expression in the CNS and in epidermis.A:
anterior, P: posterior. C) Wild type adult fly showing normal wings and halteres.
abx bx3 pbx homocygote showing a very strong haltere to wing transformation.
Adult flies pictures taken from (Lewis, 1998).
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Figure 1.9: RNA processing of Ultrabithorax. A) Scheme representing the transcript
organisation. Boxes represent coding exons, constitutive exons in blue, microexons
I and II in red and green respectively. Gray bars represent 5’ and 3’ UTRs and
lines represent introns. Dotted lines represent the alternative splicing routes. B)
Splicing and polyadenylation isoforms produced. The scheme on the left represent
the six isoforms produced by the inclusion or exclusion of the alternative exons. On
the right the two polyadenylation isoforms is shown. Arrowheads mark position of
cleavage and polyadenylation.
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and by the use of a proximal or distal donor splice site in the 5’ exon (B element).
Alternative splicing then produces six protein isoforms: Ib (B element, mI and mII),
Ia (mI and mII), IIb (B element and mII), Ia (mII), IVb (B element, no microexons)
and IVa (no microexons) (Figure 1.9B).
The difference between the protein isoforms produced is relatively small, so eluci-
dating if they are functionally different has proven to be a challenge. Initial research
produced little evidence for a differential role of each protein isoform: a chromosomal
inversion around mII that produces only the IV isoform (Ubx MX17 does not show
any morphological difference at embryonic or larval stages to wild type flies (Bisturia
et al., 1990). This result suggests that the Ubx IV isoform is able to successfully
substitute Ubx normal expression at those stages, in the epidermal tissue. Moreover,
over expressing individual Ubx isoforms under a heat shock promoter (hsp 70) leads
to a similar thoracic to abdominal transformation in the ventral cuticle in instar 1
larvae (L1) suggesting the interchangeability of the isoforms (Mann and Hogness,
1990). However, the same hsp 70 promoter-Ubx constructs show a different effect of
Ia or IVa Ubx isoforms in the peripheral nervous system: Ia isoform overexpression
leads to an abdominal transformation of PNS at parasegments 3, 4 and 5 whereas
IVa isoform does not, suggesting a differential role (Mann and Hogness, 1990). New
evidence has shown that the 3’ exon contains the homeodomain (HD) and the 5’
exon contains the YPWM motif (Figure 1.9) which plays an important role in the
protein interaction between Ubx and Extradenticle, enhancing Ubx DNA specificity
and binding. The inclusion or exclusion modifies the distance of these two domains
in the Ubx protein, potentially changing its properties (Passner et al., 1999),(Reed
et al., 2010) Figure 1.9A and 1.10).
In S2 cells, Ubx isoforms IIa and IVa show a slightly stronger ability to activate
an Ubx target reporter (Krasnow et al., 1989). Recent studies have confirmed that
protein isoforms of Ubx behave differentially in vitro and in vivo. An in vivo exper-
iment using a Ubx mutant that produced a strong haltere-to-wing transformation
was rescued by the expression of specific splicing isoforms of Ubx and the results
showed that Ia isoform has a higher ability to rescue the haltere phenotype than the
IVa isoform (Figure 1.10 C-H) (Reed et al., 2010), (de Navas et al., 2011).
Ubx mRNA is also alternatively polyadenylated. Two polyadenylation sites have
29
been characterised. The use of the first PAS (proximal) produces a 3.2 kb transcript
that appears at 3 hAEL and the use of the second PAS (distal) 4.3 kb one that
appears at 6 hAEL and peaks at 12-15 hAEL (O’Connor et al., 1988), (Kornfeld
et al., 1989). Bender’s group managed to isolate neuroblasts and culture them for
18 h and found that they produced more long UTR isoforms compared to isolated
myoblasts. Splicing isoform analysis in the same cells revealed that the I isoforms are
more abundant in the myoblasts and the IV isoforms in the neuroblasts, suggesting
a tissue specific distribution of the isoforms rather than segment specific (O’Connor
et al., 1988).
Ubx shows a correlation between splicing and polyadenylation patterns: Ubx
isoforms retaining both microexons (i.e. Ubx I) are more associated with shorter
3 UTR tails determined by a proximal pA (S), while splicing forms in which the
microexons are spliced out (i.e. Ubx -II and Ubx - IV) possess longer 3 UTR sequences
(L) (O’Connor et al., 1988), (Kornfeld et al., 1989). This pattern of splicing and
polyadenylation isoforms is conserved among distant Drosophilids, suggesting an
important function for development (Bomze and Lopez, 1994).
Ubx expression levels can be also regulated posttranscriptionally by the miR-
iab4/iab8 microRNAs (miRNAs) acting on specific target sites located in Ubx distal
3 UTR (Bender et al., 1983), (Ronshaugen et al., 2005), (Bender, 2008),(Bushati
et al., 2008), (Tyler et al., 2008). Bioinformatic studies revealed that most of these
miRNA target sequences are positioned within the Ubx 3 UTR tail precisely in the
region that is affected by the alternative pA process described above (Patraquim
et al., 2011)(Figure 1.11) and that they are evolutionarily conserved. Altogether,
these observations suggest that Ubx AS, pA and miRNA-regulated Ubx expression
levels may be functionally interlinked during development. This possibility would
concur with the new molecular views of gene expression as an extensively coupled
network instead of a sequential assembly line (Maniatis and Reed, 2002). Recent
work highlights the relevance of these views in the context of animal development
and its evolutionary variation (Alonso and Akam, 2003), (Alonso and Wilkins, 2005).
Proper identity establishment of segments during development is crucial for
the correct diversification of neuronal circuits that run along the anterior-posterior
axis. This ensures the integration of sensory signals coming from the environment,
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Figure 1.10: Alternative splicing of Ultrabithorax. A) Representation of the Ubx
transcript showing the constitutive exons in black, the 5’ exon contains the YPWM
motif shown as a blue bar, the 3’ exon contains the homeodomain, represented
with a white bar (HD). The gray bars represent the alternative microexons mI
and II. 5’and 3’ UTRs are shown as thick gray lines. The arrow at the 5’ end
marks the position of transcription initiation. B) The Ubx isoforms produced by
the alternative inclusion of mI and mII only. C-H) Rescue experiment of an Ubx
mutant using different Ubx protein isoforms. C) Wild type fly showing normal wing
and haltere. D) Higher magnification picture showing the normal wild type haltere.
E) Ultrabithorax mutant background (UMB) used for the rescue experiments, shows
a haltere to wing transformation, picture at the same magnification as D. F) UMB
fly over expressing the Ia isoform showing a total rescue of the wing phenotype. G)
UMB fly over expressing the IIa isoform showing a less strong rescue of the wing
phenotype. H) UMB fly over expressing the IVa isoform showing a very weak rescue
of the wing phenotype. Pictures taken from (de Navas et al., 2011).
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Figure 1.11: The longer 3’ UTR from Ubx contains regulatory elements/ A) Scheme
representing the alternative polyadenylation of Ubx resulting in a long 3’ UTR of
2350 nt or a shorter 3’ UTR of 990 nt. The longer portion of the 3’ UTR contains
more putative miRNA binding sites. B) mCherry fused to the short 3’ UTR of Ubx
shows a uniform expression when an elav driver is used. C) When the long 3’ UTR
is used, a down regulation is observed towards the posterior region of the embryo.
Blue figures at the bottom represent the construct expression profile. A, anterior;
P, posterior; asterisk marks unspecific signal from the salivary glands. Taken from
(Thomsen et al., 2010).
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needed for locomotion and behavioral decisions. Each hemisegment produces 30
neuronal stem cells or neuroblasts (NB) that reads the signals from the neuroecto-
derm to acquire individual lineage identities. These identities are similar but still
have segment-specific identity and are called serial homologs. This fine tuned iden-
tity is achieved by neuroblast specification, differential cell death and proliferation
(Rogulja-ortmann and Technau, 2008), (Rogulja-Ortmann et al., 2008), (Estacio-
Go´mez et al., 2013), (Dixit et al., 2013). Given the role of Hox genes in determining
anteroposterior axis it is likely that they are responsible for the establishment of
neuroblast identity in each segment. For example, the NB1-1 lineage is specified by
Ubx and Abdominal A and it produces neurons and glial cells in abdominal seg-
ments but in thoracic segments, it only produces neurons. In abdominal segments,
Ubx is needed for the suppression of the thoracic NB6-4 lineage. Ubx also activates
segment specific cell death, eliminating the GW neuron fate from lineage NB7-3 in
T3 and abdominal segments (Rogulja-Ortmann et al., 2008).
Ubx offers a very good tool to explore what factors are involved in the con-
trol of alternative splicing and polyadenylation during embryonic development of
Drosophila.
1.6 Aims of the study
Proper RNA processing is crucial for the correct expression and function of genes.
However, little is known about the precise mechanisms that underlie the production
of specific splicing and polyadenylation isoforms during development. The aim of
this study was to increase our understanding of the factors involved and their mech-
anisms in the establishment of mRNA splicing and polyadenylation isoform patterns
during embryonic development. This project used the Ubx gene to explore the role
of some candidate factors in the control of alternative splicing and polyadenylation
and describes the direct interaction between Ubx mRNA and one of these proteins
(Elav), demonstrating that the mechanism for its control involves a direct contact
within intronic sequences.
Elav plays important roles in the mRNA processing of other mRNA targets (ewg
and Neuroglian) in the CNS during embryonic and larval stages. Its expression
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partially overlaps Ubx expression in the CNS at embryonic stages, making them
likely to interact, so the first aim was to test if they do. I first tested whether
Elav affects the mRNA processing of Ubx by RT-PCR experiments using RNA
extracted from whole embryo elav null mutants. I asked if Elav affects the splice
site choice between the alternative exons changing the balance of isoforms produced.
I asked if Elav plays a role in polyadenylation site selection as well, using the same
experimental strategy. I also explored other possible effects of the elav null mutant
in the Ubx gene, such as mRNA abundance and protein production.
Once the interaction between Elav and Ubx mRNA was established, I sought to
determine the nature of such interaction. For this, I asked wether Elav is able to
bind directly to elements within the Ubx mRNA in vitro. For this, a bioinformatic
search for potential Elav binding sequences was carried out by Pedro Patraquim,
member of the Alonso Lab.
A third aim was to extend the search of candidate factors that also contribute to
the finely controlled processing of Ubx mRNA during embryonic stages of develop-
ment. For this we asked whether selected candidate factors affect the splicing and
polyadenylation patterns of Ubx mRNA, using the same experimental strategy used
for the Elav factor.
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Chapter 2
Materials and Methods
2.1 Drosophila melanogaster culture
Drosophila melanogaster flies were kept in plastic vials or bottles with standard
molasses food, at 25◦C or room temperature. Oregon Red was used as wild type in
all the experiments.
2.1.1 Collection of embryos
Apple juice agar plates were used to collect embryos from collection cages. 5 cm
diameter plates were used with small collection cages and 9 cm diameter plates with
big collection cages. For 500 ml of apple juice agar, 12 g of agar, 12 g of sugar, 125
m of apple juice were combined. Agar was melted in a microwave and poured in the
plates. Live yeast paste was spread on the plate and covered with a piece of tissue
before use.
2.2 Embryo dechorionation and fixation
Embryos were collected in a small funnel net and yeast was rinsed with tap water.
Dechorionation was done with 50% bleach for 5 minutes. Embryos were rinsed
with tap water. Embryos for antibody staining were fixed using 0.66 mL 4% (v/v)
paraformaldehyde in PBS and 2 mL of heptane in vigorous agitation for 20 minutes.
Lower phase was discarded and 1.5 ml methanol was added, and vortexed for one
minute. All liquid was removed and embryos were rinsed with 1 ml methanol four
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times and stored at -20◦C in methanol.
2.3 Whole embryo antibody staining
Fixed embryos in methanol were rinsed with PBT (0.1% (v/v) Triton X-100 PBS)
and washed 3 times for 10 minutes. Primary antibody was incubated overnight at
4◦C in gentle agitation (anti-Ubx diluted in PBT 1:20, anti-GFP 1: 300, rat anti-
Elav 1:300). Embryos were rinsed 3 times with 1 ml PBT and washed 3 times for
10 minutes. Secondary antibody was incubated for 2 hours at room temperature
(anti mouse 1:1000, anti rabbit 1:1000). DAPI was added at 1:200 for the last 10
minutes of incubation. Embryos were rinsed 3 times in PBT and washed 3 times for
20 minutes, then rinsed 2 times in PBS, all liquid was removed and 70% Glycerol
in PBS was added. Embryos were mounted in 70% (v/v) Glycerol in PBS on poly-
lysine slides.
2.4 RNA extraction
RNA was extracted using the TRIzol R© reagent (Invitrogen Cat#15596-026). At
least 50 dechorionated embryos were homogenized and lysed using a sterile pestle in a
1.5 ml eppendorf tube containing 100 µl of TRIzol R© reagent. After homogenization,
volume was adjusted to 500 µl or 1000 µl depending on the number of embryos. 200
µl of chloroform per ml of TRIzol R© were added and vortexed for 15 seconds.The
tubes were incubated at room temperature for 5 minutes and then centrifuged to
separate phases. The resulting supernatant was transferred to a sterile, nuclease-
free tube for precipitation using 500 µl of isopropanol per ml of initial TRIzol R©.
The RNA was precipitated by centrifugation at 4◦C for 30 min at top speed in a
top table centrifuge. The supernatant was decanted and the pellet dried. RNA was
resuspended in 20-50 µl of milliQ sterile water to a final concentration of 3 µg/µl.
2.4.1 DNA digestion
DNA was eliminated from the RNA samples by digestion using DNaseI enzyme from
New England Biolabs (Cat#M0303S) at 37◦for 10 minutes. Reaction was stopped
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by heating the sample at 75◦C for 10 minutes.
2.5 cDNA synthesis
cDNA was synthesized using the RETROscript R© kit (Ambion Cat#AM1710M)
following the manufacturer’s instructions for the Two-step RT-PCR with heat de-
naturation of RNA protocol. One microgram total RNA was combined with either
random decamers or oligo(dT) primers and nuclease-free water, then denatured at
85◦C before the addition of the remaining RT reagents: 10X RT buffer, dNTPs,
RNase inhibitor, and the M-MLV Reverse Transcriptase. Reverse transcription of
cDNA was carried out at 42◦C for 1 hour. The reaction was stopped by inactivating
the reverse transcriptase at 92◦C for 10 minutes.
2.6 Primer design and Polymerase Chain Reac-
tion (PCR)
Primers were designed using the tool Primer3 (http://bioinfo.ut.ee/primer3/) using
the default settings. For Ubx Universal and Distal, primers previously published
were used (Thomsen et al., 2010), (Burnette et al., 1999). Primer stocks were
resuspended in TE buffer (10mM Tris, 1mM EDTA, pH 8.0) at 100 µM, working
solutions 10 times dilutions in distilled water. PCR reactions were carried out using
one unit of Taq polymerase (New England Biolabs - Cat#M0273S), 1 µl of each
forward and reverse primers, 0.5 µl dNTP mix (10 mM each), 1µl cDNA, in a final
volume of 25 µl of 1 X Taq buffer. A typical reaction used the following program:
1 cycle DNA denaturation at 94◦C - 5 min
29 cycles denaturation at 94◦C- 30 seconds
annealing at 51-58◦C- 30 seconds
extension at 72◦C- 30 seconds to 1 min
1 cycle final extension at 72◦C- 10 minutes
Hold at 4◦C
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2.7 Agarose gel electrophoresis
DNA visualisation was carried out using agarose/ethidium bromide gel electrophore-
sis. 1% agarose gels were prepared in SB buffer (Sodium borate 10mM, pH 8.2)
(Brody and Kern, 2004) and 0.5 µM ethidium bromide. DNA ladder New England
Biolabs 100 pb (Cat #N3231S) or 1 kb (Cat#N3232S) were used as reference. Gels
were run at 10 Volts per cm. The analysis of band intensities was carried out with
ImageJ software. The image from the gel obtained from the gel documentation
station was open in the ImageJ software, the background signal was substracted
and the bands were measured by drawing a square around them and measuring
its integrated density, which gives the sum of pixel values within the selected area.
The values obtained were copied in an Excel spreadsheet for statistical analysis and
graph design.
2.8 Gene cloning
TA cloning was performed with Taq PCR products and pGEMT-Easy vector sys-
tems (Promega Cat#A1360) following manufacturer’s instructions. Ligation was
performed overnight at room temperature and bacteria were transformed by heat
shock at 42◦C for one minute. Recovery was allowed at 37◦C with 1 ml LB media
and plated on ampicilin LB plates. Cloning for sequencing was performed with PCR
products using Phusion high fidelity enzymes from New England Biolabs (Cat#
M0530S) and A overhangs were added with one unit of Taq polymerase, 0.2 mM
dATP (or dNTP mix) at 72◦C for 30 minutes.
2.9 Site-Directed Mutagenesis
Primers used were designed using the Quick Change II site-directed mutagenesis
online tool from Agilent technologies and were adjusted to 50 bp long. They were
synthesised by Sigma using standard protocols. The Phusion enzyme (NEB Cat#
M0530S) was used for the amplification reaction under the following conditions: 50
to 100 ng of template plasmid was used, mixed with 1 µl of each oligo (10 nMol ), 10
µl of 5X Phusion buffer, 1 µ lof dNTPs 10 mM, 1 µl of the Phusion polymerase and
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distilled water up to 50 µl. The amplification conditions were as follows: 95◦C for
2 minutes, then 95◦C for 30 seconds, 55◦C for 1 minute, 68◦C for 2 min/kb. These
last three steps were repeated 20 times. Then, 1 µl of DpnI restriction enzyme
was added for 1.5h at 37◦C to digest the template bacterial produced plasmid. A
no primer and a no DpnI control were performed. 1 µl of the reaction was used
to transform 30 µl of competent E. coli Dh5α bacteria using standard protocols.
Colonies were picked and minipreps performed to be send to sequence with T7 oligo
primer (MWG Eurofins). The identified colonies were then cultivated in 50 ml LB
media for midiprep preparation.
2.10 Mini and midipreparation of plasmid DNA
For plasmid purification, the QIAprep Spin Miniprep (Cat#27106) or Midiprep
(Cat#12143) were used according to the manufacturer’s instructions. The final
plasmid was eluted in a volume of 50 µl of distilled water.
2.11 SDS Polyacrylamide gel electrophoresis
Mini-PROTEAN R© Tetra Cell (Biorad Cat#165-8000) system was used. The glass
plates were washed with soap and then rinsed with tap water, distilled water and
ethanol. They were cast in the casting system with the gel mix using 37.5:1 acry-
lamide to bisacrylamide stabilized solution (ProtoGel from National Diagnostics) as
shown below.
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Resolving gel Stacking gel (4% acrylamide)
Component (12% acrylamide) (4% acrylamide)
dd H2O 4.35 ml 3.2 ml
1.5M Tris-HCl, pH 8.8 2.5 ml -
0.5M Tris-HCl, pH 6.8 - 1.25 ml
10% SDS 100 µl 50µl
Acrylamide/bisacrylamide 3 ml 500 µl
(37.5:1, 40% sol.)
10% Ammonium Persulfate 50µl 25µl
TEMED 5 µl 5µl
Both mixes were prepared without APS and TEMED. These components were
added to the resolving gel, mixed and poured. 50% isopropanol was layered on top of
the gel to nivelate the gel. When the resolving gel was polymerized, the isopropanol
was removed and APS and TEMED were added to the stacking gel, mixed and
poured, placing the comb on top. Samples were mixed with 2X Protein Loading
Buffer and boiled for 5 min or incubated at 85◦C for 10 mins. The gel was run at
200V for 45 mins.
2.11.1 Buffers
Running buffer
For 1L, 10X buffer, the following was combined:
Tris: 30.27 g, glycine: 144.13g, SDS: 10g, pH 8.8.
Protein Loading Buffer
for 10 mL volume final concentration
SDS 10% 4ml 4 % (w/v)
Tris-HCl 0.5M pH 6.8 2 ml 100 mM
Bromophenol blue 0.5% 2 ml 0.1% (w/v)
Glycerol 2 ml 20% (v/v)
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2.12 Western Blot analysis of proteins
The proteins were transfered at 100 V for at least 2 hours to a nitrocellulose mem-
brane (GE Healthcare Hybond ECL Membrane Cat#RPN203D). The membrane
was stained temporarily with Ponceau red (Sigma Cat #P7767) to control for the
efficiency of the transfer. The Ponceau was washed with distilled water and the
membrane was blocked with 10% (w/v) non fat dry milk in PBT 0.05% Tween for
1h at room temperature and shaking. The primary antibody was diluted in 5%
(w/v) milk in PBT 0.05% Tween and incubated overnight at 4 ◦C and shaking. The
antibodies used were diluted as follows: anti Ubx (FP3.38)-1:100, anti-Elav-1:400,
anti-H3P 1:1000. The primary antibody was washed with PBT 0.05% Tween 3
times for 20 minutes and then the secondary antibody was incubated in 5% (w/v)
milk in PBT 0.05% Tween for 2h at room temperature and shaking. The secondary
antibodies were diluted in PBT 0.05% Tween as follows: anti mouse 1:1000, anti-
rabbit 1:500, anti-rat 1:1000. The signal was developed using the Amersham ECL
Western Blotting Detection Reagents (Cat#RPN2109), used as indicated by the
manufacturer. The membrane was exposed to films (Amersham Hyperfilm ECL
Cat#28906835) for 5 min, 30 min and 2 hours.
2.13 Nuclear extract
I used a protocol designed by the Laboratory of Donald Rio (University of California,
Berkeley) as described in the Rio Lab Protocols Compendium 2007, provided by
Julie Aspden ”hnRNPs-enriched Nuclear Extract”.
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2.13.1 Solutions
HNEB1
final concentration for 100 ml stock solution
15 mM HEPES pH 7.6 1.5 ml 1M (pH 5.5)
10 mM KCl 0.33 ml 3M
350 mM sucrose 11.9 gr powder
2.5 mM MgCl2 0.25 ml 1 M
0.1 mM EDTA 0.02 ml 0.5 M
The solution was adjusted to pH 7.6 with KOH.
HNEB2
final concentration for 50 mL stock solution
10 mM Tris pH 7.5 2 ml 1 M
100 mM NaCl 1 ml 5M
2.5 mM MgCl2 0.125 ml 1M
0.5% Triton X-100 1.25 ml 100%
Add protein inhibitor prior to use (ROCHE Cat#04693124001)
2.13.2 Procedure
1-2 mg of overnight embryos were collected on big apple juice agar plates, the eggs
were recovered from the plates, rinsed in baskets and dechorionated as described.
Embryos were transfered to a 50 ml falcon tube with PBS, all liquid was removed
and weight of embryos was determined. Embryos were resuspended in 2 ml of
HNEB1 per gram and transferred to a medium dounce. Falcon tubes were rinsed
with 2ml per gram of embryos and mixed to embryo suspension. The embryos were
smashed with a loose pestle, using 5 strokes on ice. The lysate was then filtered
with one layer of miracloth. The dounce was rinsed with 1 ml per gram of embryos
and filtered as well. The filtrate was then transfered to a 15 ml glass centrifuge
tube and centrifuged in a Sorvall at 9,100 rpm (10,000g) in a SS-34 rotor for 15
minutes at 4◦C. The supernatant was decanted and disposed. The pelleted nuclei
were resuspended in 1ml of HNEB2/gram of embryos. The very solid yolk pellet was
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eliminated. The nuclei were transfered to the douncer again and smashed with the
tight pestle with 15 strokes on ice. A volume of HNEB2/30% sucrose equal to that
of the smashed nuclei was placed in a glass tube and the smashed nuclei overlayed
on top. The nuclei were centrifuged for 15 min in a Beckman SWI28 rotor with
no brake, at 6,350 rpm (4,800 g). Four fractions were obtained; the top one was
eliminated (lipids) and the second one was recovered (nuclear extract). Glycerol
was added to 15% (v/v) and 40 µl aliquots were made and frozen in liquid N2.
2.14 Labelling of RNA with 32P
500µl of digested gel purified plasmid was mixed with 2µl T7 polymerase buffer, 0.75
µl of unlabelled ATP, CTP, GTP; 0.5 µl RNAse inhibitor; 1.5 µl T7 polymerase;
2µl of 32P UTP (3000Ci/mmol, BLU007H250UC, Perkin Elmer); water was added
up to 20 µl. The reaction was incubated at 37◦C for 2 hours.
2.14.1 Gel purification of labelled probe
The in vitro transcription reaction (20 µl) was mixed with 30 µl of water and non
incorporated rNTPs were separated using illustra ProbeQuant G-50 micro columns
(GE Healthcare). The probe was purified for a second time using a denaturing
polyacrylamide gel. To prepare the gel, 20 g of urea were dissolved in 18.2 ml
distilled water at 50◦C. 2 ml of 10X TBE, 5 ml of 40% acrylamide 19:1 Acrylamide
to bisacrylamide stabilised solution (National Diagnostics) were added and mixed
well. 400 µl of 10% ammonium persulfate and 25 µl TEMED were added at the
end and poured immediately. When the gel was polymerised, it was mounted to the
tank and 1L of 1X TBE was added. Wells were flushed before loading the samples
and run the gel at 400 V for 1h. To determine probe yield and specific activity,
I used the method described by Ambion (http://www.biocompare.com/Applica
tion-Notes/42363-Determining-RNA-Probe-Specific-Activity-And-Yield/). This
method first calculates the theoretical maximum yield of RNA given the individual
nucleotide concentration considering rUTP as the limiting component. Afterwards,
the incorporation efficiency is calculated by measuring the cpm of labelled RNA
before and after purification. With this information, it is possible to calculate the
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theoretical amount of labelled RNA produced. To confirm that the probes were
evenly quantified, I resolved 1µl of RNA sample in a denaturing polyacrylamide gel
and exposed it to a phosphoimager plate.
2.15 Recombinant Elav production
The recombinant GST-Elav protein was obtained using a pGEX-GST vector (kindly
donated by M. Soller) were the Elav open reading frame was inserted downstream
of the GST tag (Soller and White, 2003). Another member of the Alonso Lab,
Ali Mumtaz carried out the purification using the following protocol: BL21 bacte-
ria transformed with the pGEX-GST-Elav construct was cultured at 37◦C until it
reached OD 600 in LB medium and then bacteria were induced at 30◦C with 0.4 mM
IPTG for 3 hours. The culture was then centrifugated and the bacterial pellet was
resuspended in Lysis buffer (PBS, 1% Triton X, 1mM DTT, 0.1 mg/ml lysozyme
and Protease Inhibitor cocktail from Roche). Cells were flash frozen and thawed at
37◦C 10 times and then lysed at 4◦C on a wheel. The lysate was then sonicated
3 times for 10 seconds in a water bath sonicator. The lysate was centrifuged and
the supernatant recovered and incubated with pre-equilibrated 50% (v/v) slurry of
anti-GST agarose beads (Invitrogen Cat #G2879)(0.5 ml bead volume per litre of
culture) for 2:30 hours at 4◦C on the wheel. The beads were washed three times with
10 volumes of beads of PBS and with PreScission Protease Buffer (50mM Tris-HCl,
100mM NaCl, 1mM EDTA, 1mM DTT pH 8.0) 2 times. Protein was eluted with
160U of PreScission Protease (GE Healthcare Cat #27-0843-01) per ml of beads
equilibrated with PreScission Protease Buffer overnight at 4◦C. Supernatant was
cleared from residual protease and GST by incubation with pre equilibrated agarose
Protein A beads. Protein concentration was determined by Bradford assay and
purity by SDS-PAGE and Coomassie staining.
2.16 UV crosslinking of proteins to RNA
700 pM of uniformly labelled RNA was incubated with 5X binding buffer (400 mM
KCl, 100 mM HEPES pH 7.6, 20 mM MgCl2, 25% glycerol and 5 mM DTT), 1 µl
of tRNA 1mg/ml and 38 µg/ul of recombinant Elav or 40% Nuclear Extract in 10
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µl. The mix was incubated at room temperature for 10 mins, divided in 2 samples,
one UV-crosslinked for 12 minutes on ice in a Stratalinker and the negative control
kept on ice, without crosslinking. The samples were digested with 0.5 µg RNAse
A at 37◦C for 15 mins. Samples were run on a SDS-PAGE and the gel was dried
and exposed to a phosphoimager plate over night (Walker et al., 1998), (Soller and
White, 2003).
2.17 Electrophoretic Mobility Shift Assay (EMSA)
The sizes of the probes used are described in the following table:
Probe Size1 Size2
ewg 235 157 nt
ewg as 257 160 nt
site3 215 nt 151 nt
site5 300 -
site8 171 nt 157 nt
site13 200 nt 153 nt
site16 192 nt 155 nt
EMSA experiments were performed as described in (Soller and White, 2003).
The first step is to prepare the Buffer mix, as follows:
2.17.1 Buffer mix
1 µl of 10X binding buffer (500 mM Tris-HCl pH 7.5, 400 mM KCl, 350 mM NaCl),
0.5 µl of BSA 1 mg/ml, 0.05 µl of DTT 0.1M and 0.5 µl of RNAse inhibitor, per
reaction.
The second step is the preparation of the RNA mix:
2.17.2 RNA mix
For a 100 pM RNA reaction and 50 g/L tRNA, the following was mixed: 3 µl
of 300 pM labelled RNA, 0.25 µl of 1 mg/ml tRNA and 1.75 µl water. The mix
was incubated at 65 ◦C for 5 mins and allow to renature at room temperature for
45
10 mins. A master mix per RNA probe was prepared to be mixed with different
concentrations of Elav.
Then, the reactions were assembled with different quantities of recombinant Elav
protein, on a chilled rack over a bucket of ice as shown in the next table:
Probe tRNA Elav nM Buffer mix RNA mix Elav protein Water
ewg 25 ng/µ 0 2.05 µl 5 µl 0 µl 2.95 µl
ewg 25 ng/µ 200 2.05 µl 5 µl 1.35 (1:10)µl 1.6 µl
ewg 25 ng/µ 400 2.05 µl 5 µl 2.7 (1:10)µl 0.25 µl
ewg 25 ng/µ 600 2.05 µl 5 µl 0.41 µl 2.54 µl
The reactions were incubated at room temperature for 20 min. The 10µl re-
action was mixed with 3 µl 50% (v/v) glycerol and loaded onto a 4% (80:1 acry-
lamide/bisacrylamide) polyacrylamide native gel and run at room temperature at
250 V in 0.5 X TBE. Gels were dried in a gel dryer and exposed on a phosphoimager
plate overnight (Walker et al., 1998), (Soller and White, 2003). The images then
were analysed with ImageJ.
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Chapter 3
The role of Elav in Ubx RNA
processing
3.1 Introduction
Ubx RNA processing during Drosophila development is a very complex and regu-
lated process. As described in the introduction, the Ubx transcript contains two
constitutive exons (E3’ and E5’) and three alternative exons (B element, mI and
mII, black, red and green respectively in Figure 3.1A) which are used to generate
a family of 6 splicing isoforms. Isoform I contains both mI and II, isoform II con-
tains only mII and IV does not contain any microexon. The isoforms containing
the B element are named b, whereas the isoforms lacking it are named a. A graphic
description of the splicing isoforms is shown in Figure 3.1A.
Ubx transcrip also undergoes alternative polyadenylation by the use of a proximal
or distal Polyadenylation Site (PAS), generating a ”short” 3’ UTR of 1kb or a ”long”
one of 2.4 kb (Figure 3.1B)
A detailed analysis of Ubx alternative splicing and polyadenylation during embry-
onic development carried out by a former member of the Alonso Lab, Lucy Williams
using semiquantitative RT-PCR approach (shown in the supplemental material in
(Thomsen et al., 2010)) is partly reproduced in Figure 3.2. In this analysis, Ubx
mRNA appears at 3 hAEL (hours after egg layed) with mainly splicing isoform Ia
and isoform IIa showing at very low levels. Both isoforms increase in abundance
along development and at 11 hAEL isoform IVa appears. By 21 hAEL the three
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Figure 3.1: Ubx alternative splicing and polyadenylation. A) The Ubx transcript
produces six splicing isoforms by the inclusion or exclusion of the B element (in
black), microexon I (in red) or microexon II (in green) (mI and mII respectively),
named Ib to the isoform containing all the elements, Ia containing mI and II, IIb
contains the B element and mII, whereas IIa contains only the mII, IVb contains only
the b element and IVa does not include any alternative exons. B) Ubx transcripts
produces a short or long UTR by the use of a proximal or a distal Polyadenylation
Site (PAS1 or 2 respectively). The use of the proximal PAS produces a ”short”
UTR of around 1kb and the use of the distal PAS produces the ”long” 3’ UTR of
around 2.4 kb. The longer the UTRs the bigger number of cis elements present in
the transcript that could potentially determine its post translational regulation, for
example, by microRNAs. Figure modified from (Kornfeld et al., 1989). C) Position
of primers along the Ubx transcript for PCR exploring splicing and polyadenylation
patterns. HD, Homeodomain; mI and II, microexon I and I; PAS, polyadenylation
site.
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isoforms are equally abundant.
The polyadenylation analysis carried out by Lucy Williams was done specifically
for each splicing isoform, with primers designed on the exon-exon junction for each
isoform and before and after the proximal polyadenylation site (scheme to the right
in Figure 3.2 B). The proximal PAS is the main polyadenylation site used in all
Ubx transcripts at 3hAEL so most of them have a short UTR. At 5 hAEL a very
small quantity of long 3’ UTR starts appearing associated with isoform Ia. As
development progresses, the long UTR is more abundant and its association shifts
to IIa at 13 hAEL, with of most of the long UTR associated to IVa isoform at 17 to
21 hAEL.
Ubx RNA generates more diversity of isoforms towards the late stages of devel-
opment and previous research have found that within the nervous system there is a
different control of RNA processing (O’Connor et al., 1988). What are the factors
that shape the splicing and polyadenylation patterns within the nervous system?
The RNA binding protein Elav emerges as a very strong candidate regulator as it is
a neuronal specific factor and its role on the splicing and polyadenylation of other
genes has been very well documented.
Previous work in the lab done by Dr. Stefan Thomsen and Elvira Lafuente
demonstrated a role of Elav in Ubx polyadenylation choice. They used a null mutant
for elav (elav5/FM6) and monitored the choice of the proximal or distal PAS of Ubx
by in situ hybridisation (ISH) using a probe against the distal region of the 3’ UTR
(Figure 3.3C-D). The results showed a clear shift from the distal PAS to the proximal
PAS in the elav mutants at stage 16 (Rogulja-Ortmann et al., 2014). Consistent
with this result, over expression of Elav at earlier stages results in an up regulation
of the longer UTR (Figure 3.3 E-F).
In this chapter I describe the role of the Elav protein in Ubx splicing and
polyadenylation. Using RT-PCR as an experimental strategy, I show that Elav
helps to shape the patterns of Ubx isoforms achieved during embryonic development
in Drosophila.
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Figure 3.2: Ubx isoforms processing during Drosophila embryonic development. A)
RT-PCR using primers on the 5’ and 3’ exons spaning the variable region and RNA
samples collected at the time points shown above. The scheme of the isoforms is
shown to the right also shows the position of the primers. The RT-PCR shows a
progressive enrichment of all the splicing isoforms during embryonic development.
B) Splicing and polyadenylation relationship, explored by RT-PCR using a forward
primer in the exon-exon junction for each splicing isoform and a reverse before or
after the proximal PAS (termed short and long respectively) as shown in the diagram
at the right. The progression of development shows a gradual increase of the use
of the distal PAS, generating more Ubx mRNA with ”long” 3’ UTR. Work done by
Lucy Williams, Figure modified from supplementary Figure 1 in (Thomsen et al.,
2010).
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3.2 Results
As described in the introduction, Ubx has two alternative micro exons and two de-
scribed polyadenylation sites that produce six splicing isoforms and two polyadenyla-
tion isoforms (Figure 3.1). The splicing and polyadenylation patterns during embry-
onic development have been determined before (O’Connor et al., 1988), (Kornfeld
et al., 1989), (Lopez and Hogness, 1991), (Artero et al., 1992), (Thomsen et al.,
2010). In this chapter, the effect of Elav in the establishment of such patterns was
determined using an elav null mutant to explore by RT-PCR the changes in splicing
and polyadenylation isoform abundance in comparison with Oregon Red (OR) wild
type flies. The stock used in this study was kindly donated by Matthias Soller and
its full genotype is: w[*] sn elav [elav5]/FM6/y[2]Y[611].
This mutant is a deletion of the open reading frame and does not produce Elav
protein (Campos, A.R., Grossman, D., White, 1985). The balancer was changed
for FM7c, GAL4-Kr.C,UAS-GFP to allow me to sort mutant homozygotes by the
absence of a fluorescent marker in late embryonic stages (Figure 3.3). Embryos
of late embryonic stages (15 onwards) were collected and RNA was isolated using
Trizol. cDNA was prepared using oligo dT under standard conditions (see details
in the Methods section).
3.2.1 Elav affects the alternative splicing pattern of Ubx
To explore the Ubx splicing patterns, primers designed around the variable mi-
croexons, in the E5’ and E3’, were used (Burnette et al., 1999), (Figure 3.1 C).
Semiquantitative PCR of late stage embryos using agarose/ethidium bromide quan-
tification showed clear differences in the splicing isoforms produced by wild type
flies compared to the elav 5 mutant (Figure 3.4A).
Initial quantification of the PCR products taking the profile of the bands of the
gel showed that in the wild type, the most abundant splicing isoform is IVa, followed
by IIa and then by IVa (Figure 3.4 A and dashed line in B). In contrast, in the elav 5
mutant, isoform Ia is more abundant than isoform IVa (Figure 3.4 A and black line
in B). Two types of analysis were performed: Ia/IIa and Ia/IVa isoform ratio and
percentage of each isoform to total Ubx.
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Figure 3.3: Elav affects Ubx PAS in late embryogenesis stage early 16. A) and B)
Antibody staining against Elav protein in wild type and elav 5 homozygote mutant
respectively. C) and D) in situ hybridisation against a region in the distal 3’ UTR
at stage 16, (scheme at the bottom) shows the normal use of the distal PAS in wild
type embryos, generating the long 3’ UTR which is reduced in the elav 5 homozygote
mutant embryos. E) Wild type embryos at the earlier stage 10 expresses very little
long Ubx 3’ UTR. F) Ectopic expression of ELAV at stage 10 shows an increase in
the expression of long 3’ UTR of Ubx, indicating that Elav is sufficient to induce a
change in Ubx polyadenylation site choice. Work by Elvira LaFuente, Figure taken
from (Rogulja-Ortmann et al., 2014).
52
The proportions of IIa and IVa to Ia isoforms are shown in Figure 3.4 C and D.
In wild type, the Ia/IIa isoform is around 0.9 which means that both isoforms have
very similar abundance. In contrast, the Ia/IIa proportion in the elav 5 mutant is 1.2:
the IIa isoform is less abundant than Ia. In relation to the IVa isoform, the Ia/IVa
ratio in wild type is 0.7, reflecting a higher abundance of IVa isoform compared to
Ia which is reversed in the elav 5 mutant: the ratio is around 2.5, reflecting much
less IVa isoform.
The analysis by isoform percentage related to total Ubx showed clearly an in-
crease of isoform Ia abundance in the elav 5 mutant from 30% to 45% whereas isoform
IVa decreases from 35% to 16% (Figure 3.4E). In contrast, isoform IIa does not seem
to be affected, shifting only from 33% to 35% and no significant difference.
In these RT-PCR experiments for Ubx splicing isoforms, the elav 5 mutant back-
ground shows changes in the balance of the Ubx isoforms produced, affecting the
exclusion of both microexons. In late stages, where there is an approximate equal
abundance of the three isoforms (Ia, IIa, IVa), the lack of Elav protein shifts the
balance towards isoforms including one or two microexons. This pattern is more
characteristic of earlier stages. This indicates that Elav is involved in microexon
splicing and that it affects both microexons. This suggests that Elav could have
a general role in alternative exon splicing, or that the elements needed for Elav
function are present in both microexons.
3.2.2 Elav changes the polyadenylation pattern of Ubx
To explore changes in polyadenylation site use, two sets of primers were designed, one
pair within the proximal region of the 3’ UTR (before the proximal polyadenylation
site) and another pair within de distal portion, after the proximal polyadenylation
site (Figure 3.1 C). The RT-PCR experiments show that at late stages of embryonic
development, there is a high production of the distal fraction of the 3’ UTR in
the wild type control, compared to the proximal UTR amplicon. In contrast, with
the elav 5 mutant, the distal band produced has a reduced intensity (Figure 3.5A).
Quantification of the intensity of the bands shows a reduction of about 30% in distal
3’ UTR production (Figure 3.5B).
These experiments demonstrated that Elav also plays a role in polyadenylation
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Figure 3.4: Elav affects Ubx splicing at late stages of embryogenesis. A) RT-PCR
using primers outside the variable region as shown in the scheme to the left. rp49
amplicon was used as loading control. B) Profile of the bands obtained showing
the top band to the left and the bottom band to the right; wild type in continu-
ous line and elav 5 mutant in dashed line. C) Proportion of Ia/IIa isoforms relative
quantification from the agarose gel showing a higher proportion of Ia in the elav 5
mutant. D) Proportion of Ia/IVa isoforms relative quantification from the agarose
gel showing a very high proportion of Ia in the elav 5 mutant, reflecting more abun-
dance of Ia isoform compared to wild type. E) Amplicons of each isoform measured
as a percentage of total Ubx mRNA. elav 5 mutant produces significantly more Ia
isoform and less IVa isoform. Bars represent standard error and * p≤ 0.05, ** p≤
0.01 of the t-test in respect to wild type.
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Figure 3.5: Elav affects polyadenylation site choice. A) RT-PCR with primers for
the proximal or distal 3’ UTR as shown in the scheme to the left for wild type or
elav 5 mutant late embryos. B) Relative quantification of the bands in the agarose
gel showing a reduction of the distal UTR of around 30% in the elav 5 mutant. Bars
represent standard error and * p≤ 0.05 of the t-test in respect to wild type.
site choice at late stages of embryonic development. The absence of Elav promotes
the use of the proximal polyadenylation site, generating a shorter 3’ UTR. These ex-
periments confirm by RT-PCR, the effect previously observed in an in situ approach
to study the role of Elav in alternative polyadenylation. This agrees with previous
reports of Elav regulating the use of alternative polyadenylation signals (Soller and
White, 2003).
3.2.3 Elav affects Ubx mRNA abundance
With the aim to establish the biological role of Elav-dependent Ubx regulation, the
previous experiments showed that Elav has a role in two Ubx RNA processing events,
splicing and polyadenylation. However, a role for Elav in other events regulating
Ubx cannot be discarded. Next, I tested the effect of Elav in Ubx expression levels.
To this end, I asked if the Ubx mRNA levels were affected in an elav 5 mutant
background. For this, primers within the E3’ exon were used in RT-PCR experi-
ments using RNA collected from wild type and elav 5 homozygote mutants at stage
16 of embryonic development. The PCR shows that the total levels of Ubx mRNA
were reduced, relative to rp49 mRNA (Figure 3.6A). The quantification of the bands
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Figure 3.6: Ubx RNA levels are reduced in elav 5 mutant. A) RT-PCR was carried
out as described in the Methods chapter using primers in the E3’ exon for total
mRNA of Ubx. PCR for elav mRNA as a control for the elav 5 mutant and rp49 as
RNA input control. B) Relative quantification of the bands in the agarose gel. Bars
represent standard error and * p≤ 0.05 of the t-test in respect to wild type.
normalised to rp49 showed a reduction of around 30% of total Ubx mRNA in the
elav 5 mutant (Figure 3.6B).
This indicates that Elav could play a role in transcription itself or that a defect
in mRNA processing is somehow leading to mRNA decay. Work in the lab by
Joao Osorio using the 35UZ Ubx-lacZ promoter fusion showed no difference in Ubx
expression in elav 5 mutant embryos compared to wild type (Rogulja-Ortmann et al.,
2014). However, fluorescent in situ hybridization (FISH) experiments using intronic
probes show that in the elav 5 mutants, Ubx transcripts get stalled in the chromosome
and accumulate there (Figure 3.7A and B) (Rogulja-Ortmann et al., 2014). Figure
3.7 C and D represent the quantification of Ubx transcription foci and intensity,
showing an increase in the elav 5 mutant.
Probably deficient splicing or polyadenylation prevents the transcript from be-
ing released from the transcription site leading to an accumulation in the chromo-
some and a decrease in the free cytoplasmic processed mRNA (Rogulja-Ortmann
et al., 2014). This is in line with previous work showing that beta-globin tran-
scripts with defects in splicing and polyadenylation are retain in the chromosome
(Carmo-Fonseca et al., 1999).
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Figure 3.7: elav 5 mutant leads to nascent Ubx RNA transcripts accumulation within
the CNS. A) Ubx nascent transcript expression detected by FISH using Ubx intronic
probes against intron 3 indicates that elav 5 mutant embryos show an overall higher
signal in Ubx nascent transcript foci. Inset shows Ubx signal detected in two discrete
nuclear foci (orange arrowheads) per nucleus (blue, DAPI). (B) Quantification of
Ubx nascent transcript expression in wild type and elav 5 mutant shows that the
distributions of Ubx nascent transcript foci [log(10)] versus voxel signal intensity
are substantially different among genotypes. Best fit curves are shown. Plotting
either the relative number of Ubx foci (middle) or relative intensity of Ubx foci (right)
detected in wild-type and elav 5 mutant embryos further confirms that mutants show
an overall higher level of expression of Ubx nascent transcripts. n=7 per genotype;
error bars indicate s.e.m.; *P¡0.05 [Wilcoxon matched- pairs signed rank test (non-
parametric t-test)]. Figure taken from (Rogulja-Ortmann et al., 2014).
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3.2.4 Ubx protein levels are reduced in the elav5 mutant
The previous experiments showed that the overall levels of Ubx RNA were reduced
in the elav 5 mutant, leading to the question of whether the protein levels were also
reduced. To this end, a Western blot was performed using whole embryos of late
developmental stages, from both wild type and elav 5 homozygote mutants. The
embryos were collected, dechorionated and homogenised in protein loading buffer.
The antibody FP3.38 against Ubx was used to detect all the protein isoforms and
the SDS-PAGE gel was able to resolve all the Ubx protein isoforms. The wild type
sample shows four distinctive bands corresponding to isoforms Ib, Ia, IIa and IVa
(Figure 3.8 A) whereas the elav 5 mutant sample shows three main bands (Ib, Ia and
IIb) and a reduced band that corresponds to the IVa isoform. A quantification of
the isoforms together reveals a small non significant reduction in total Ubx protein
levels (Figure 3.8B) which might only correspond to the missing IVa isoform. The
reduction in total protein is not as evident as the reduction observed in total RNA.
However, analysing the individual isoforms, the changes are more evident (Figure
3.8C). The increase of isoform Ia and decrease of IIa and IVa is small but significant.
Comparing the RNA and protein products of Ubx, we observe that the Ia, IIa and
IVa RNA isoforms show a similar level of expression, around 30% each. However,
at protein level there is a decreased expression of the IVa isoform (less than 20%)
(Figure 3.8C). In other words, isoform IVa shows higher expression at the RNA
levels compared to the protein levels. This discrepancy could be explained by a
translational lag, in other words, the protein isoforms reflect the RNA isoforms
pattern of a previous developmental stage.
I also observed that in an elav 5 mutant background, the proportion of Ubx
protein isoforms also changed compared to those seen in the wild type background.
The isoforms containing one (isoform IIa) or two microexons (isoform Ia) are more
abundant in the elav 5 mutants than in the wild type condition. Comparing RNA
and protein levels, the effect of the elav 5 mutant, although in the same direction,
is more evident at the RNA level, showing a 30% increase in isoform Ia and a 50%
decrease in the IVa isoform. The magnitude of the change at the protein level is
only of 15% for isoform Ia and less than 10% for IVa isoform (Figure 3.8C).
Complementary work done by Joao Osorio using antibody staining in dissected
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Figure 3.8: Ubx protein levels are also reduced in elav 5 mutant. A) Western blot
using antibodies against Elav as a control for the elav 5 mutant, H3P as loading
control and Ubx. The identity of the protein isoforms is shown in the scheme at the
left. B) Quantification of relative levels of total Ubx protein in wild type and elav 5
embryos. C) Protein isoforms each measured as a percentage of total Ubx protein.
elav 5 mutant produces significantly more Ia isoform and less IIa and IVa isoforms.
Bars represent standard error and * p≤ 0.05 of the t-test in respect to wild type.
embryonic ventral nerve cord shows a more marked decrease in the Ubx protein
levels in the elav 5 mutant (Rogulja-Ortmann et al., 2014). This could be explained
by the fact that the Western blots were performed using whole embryos, containing
Ubx expressing in non-neuronal tissue (epidermis, muscle and gut) that would not
be affected by the elav 5 mutant.
3.2.5 Ubx isoforms during embryonic development
Ubx RNA processing changes during normal embryonic development, as described
in the introduction (Figure 3.2) and Elav is partly responsible for the establishment
of such patterns. We wondered if Elav plays a role in the establishment of Ubx RNA
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patterns at other stages of development, so we focused in discrete late embryonic
stages. The elav transcript appears at stage 9 of development, on the onset of
neuron differentiation. Elav protein starts accumulating at this stage so we tested
later stages the effect of its absence. We tested stage 15, early 16, late 16 and 17
for RNA splicing isoforms by RT-PCR and also protein isoforms by Western blot.
RT-PCR of the embryonic stages sampled show a gradual increase in isoform IVa
abundance in wild type samples that is observed at RNA and protein levels (Figure
3.9 A and B). At the first stage sampled, stage 15, the isoform IVa is absent and
starts to appear at early 16 stage (E16). It continues to increase in stage late 16
(L16) and at stage 17, compared to the other isoforms. Isoform IIa at stage 15 is
equally abundant to isoform Ia and increases slightly in abundance as development
progresses, so at stage 17 it is sloghtly more abundant that isoform Ia. These trends
can be observed at the RNA and protein levels (Figure 3.8 A and B). However, in
the elav 5 samples, the isoform IVa is absent form stages 15 and early 16, and a very
weak band appears until late 16 and is visible only until stage 17. This effect is also
evident at both RNA and protein levels (Figure 3.8 A and B). The isoforms Ia is
more abundant in the elav 5 mutant at all the samples tested and at both RNA and
protein levels.
The difference of Ubx isoform pattern between wild type and elav 5 might be
explained by a delay on the development of the central nervous system, to test this,
a neuronal marker can be used at the developmental stages used for Ubx RNA and
protein analysis.
3.3 Discussion
In this chapter I describe the role of Elav protein in some aspects of Ubx RNA
processing during embryonic development. Using a null mutant, I demonstrated
that Elav affects splicing and polyadenylation decisions, total Ubx RNA and protein
levels are also affected.
60
Figure 3.9: Elav affects Ubx splicing during development. A) RT-PCR using primers
around the variable region showing the splicing isoforms produced in the control wild
type and homozygote elav 5 embryos at stage 15, early 16, late 16 and 17. Primer
position as shown at the left. B) Western blot using whole embryos at stage 15, early
16, late 16 and 17 of wild type and elav 5 homozygote embryos. Anti-Elav antibody
was used to confirm the reduction of Elav protein in the mutants. The anti-Ubx
antibody is able to detect all the Ubx isoforms, showing that in the elav 5mutant the
isoform IVa is less produced.
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3.3.1 Elav affects Ubx splicing decisions
Elav showed a role in splicing of Ubx, promoting the exclusion of both microexons.
This results confirm the role of Elav in exon exclusion, already observed in the Fas
in human and arm in Drosophila RNAs, in both transcripts, the presence of Elav
promotes the exclusion of the alternative exon whereas its absence leads to exon
inclusion. In the human Fas transcript, a sequence within the alternative exon was
demonstrated to be needed for Elav regulation of splicing (Izquierdo, 2010). In our
system, however, no U rich sequence that could be a candidate for Elav binding
site exists within the microexons, but an informatics approach carried out by Pedro
Patraquim in the Alonso Lab has revealed some candidates sequences within the
introns. The functional analysis of such sequences is the subject of the next chapter.
3.3.2 Elav affects Ubx polyadenylation decisions
In the same way, at earlier stages of embryonic development, the polyadenylation
site prefered is the proximal one. Later on, the distal PAS is also used. The presence
of Elav promotes the use of the distal polyadenylation site, generating a longer 3’
UTR, characteristic of the neural Ubx mRNA (Smibert et al., 2012). It has been
demonstrated that a longer 3’ UTR allows a more fine tuning of the regulation of
the mRNA molecule, by various mechanisms, like miRNAs, ARE binding proteins,
among others (Flynt and Lai, 2008), (Mayr and Bartel, 2009), (Thomsen et al.,
2010), (Bava et al., 2013), (Li and Lu, 2013). Elav also demonstrated to play a
role in PAS choice of a subset of transcripts in the CNS (Hilgers et al., 2012).
The difference observed in the production of a long 3’ UTR by usage of the distal
polyadenylation site between the wild type and the elav 5 mutant is about 30%. This
suggests that Elav is not the only factor involved in this process as observed in other
cases, such as Dm ewg.
3.3.3 Elav affects total Ubx RNA and protein levels
An observation made during the course of these experiments is the reduction of to-
tal Ubx mRNA in the elav 5mutant. In situ hybridisation experiments with intronic
probes done in the Alonso Lab by Joao Picao show an accumulation of non released
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RNAs from the site of transcription in the chromosome which can explain the reduc-
tion of mature Ubx mRNA in the elav 5mutant. This suggests that the role of Elav
in the correct splicing of Ubx is very important for the expression of this gene, such
that in its absence the transcript is not properly released from the transcription site.
This raises the question of what happens then in non neuronal tissues that do not
express Elav normally. Are other proteins covering the role of Elav in non neuronal
cells? If so, what is the identity of such proteins? What are the molecular mecha-
nism that allows proper release of the spliced and polyadenylated transcript? At the
protein level, the Ubx isoform pattern observed in the elav 5mutant compared to the
wild type is changed in the same direction as the observed at the RNA level but is
not at the same extent. The differences between elav 5mutant and wild type patterns
are more evident at the RNA level. This might be derived by differential translation
efficiency of each isoform contrary to previous reports (Subramaniam et al., 1994).
Alternatively, this discrepancy could be explained by translational delay: at earlier
stages, Ia isoform is more abundant and IVa is less abundant.
3.3.4 Elav modifies Ubx RNA patterns during embryonic
development
The change in the pattern of Ubx isoforms observed between the wild type and the
elav mutants is also observed in earlier stages: the isoform IVa appears later in
development (stage 11) as observed in Figure 3.2. However, the effects at earlier
stages are more difficult to study because the Elav protein is less abundant in the
control stock.
3.3.5 The relationship between splicing and polyadelylation
The experiments performed in this chapter show that Elav effects both splicing
and polyadenylation processes in Ubx RNA processing. Previous studies reported
Elav/HuR involvement in splicing independently of polyadenylation in human RNAs
(Izquierdo, 2010), but no previous reports have demonstrated Elav/HuR involved in
both processes in the same mRNA molecule. This leads to the question if Elav could
be the factor involved in the coupling of these two events, or if these are two separated
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and independent events. Given the long size of the Ubx transcript, it is possible
to consider that the effect on splicing and polyadenylation occur independently.
However, previous studies demonstrate that the mRNA molecule can be folded and
sequences far away can be brought together. So there is a possibility that Elav
protein serves as a direct link for these two regulatory events. Moreover, the role of
the RNApol-II CTD as a platform for regulatory proteins could provide a anchoring
point for Elav.
Our results show that Elav has a partial effect on splicing and polyadenylation
of Ubx RNA. These results can be explained by the use of whole embryos instead of
dissected CNS in the experiments done here. Another explanation could be that the
alternative splicing and alternative polyadenylation decisions in Ubx transcripts are
regulated by more factors, not Elav only. It is possible that the combination of a
number of factors is needed in certain proportions to change the use of splicing and
polyadenylation sites. The exploration of other potential candidates for Ubx RNA
processing is the subject of the 5th chapter.
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Chapter 4
Elav binds Ubx mRNA directly
4.1 Introduction
The HuR/Elav family of proteins have a crucial role in mRNA processing (Lisbin
et al., 2001), (Soller and White, 2003), (Zhu et al., 2007), (Dai et al., 2012); RNA
stability (Ratti et al., 2006) and even transcription and translation (Antic and Keene,
1997), (Meng et al., 2005), (Rivas-Aravena et al., 2009). How can an RBP play so
many diverse roles? The answer might lie in its biochemical properties, in the
structure of the protein and its ability to recognise and bind its targets (Figure 4.1).
The HuR/Elav family of proteins contains three RNA recognition motifs (RRM),
two of them close together and the third one separated by a hinge that contains a
Nuclear localisation signal (Samson, 2008). The RRM domain is a common feature
of RNA binding proteins and it is composed by around 80 aa containing two ribonu-
cleoprotein motifs of eight (RNP-1) and six (RNP-2) amino acids. This domain is
arranged in four beta-sheets packed against two alfa helices (Gamberi et al., 2006),
(Benoit et al., 2010) (Figure 4.1C). Crystallography studies in the human proteins
have shown that the RNPs form a cleft where the RNA molecule fits (Benoit et al.,
2010) (Figure 4.1C). In mammals, the first RRM has the main RNA binding activity
and RRM2 has a supporting role. The third domain is separated by a 60-87 amino
acids hinge. InDrosophila the main role of the third domain is the multimerisation
of the protein (Toba and White, 2008).
The mammalian homolog has an stimulatory effect in translation, by enhancing
RNA circularisation. The human HuD interacts with the polysomes, the RRM3
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Figure 4.1: Elav protein structure. A) Scheme of the Elav protein domains. The
numbers mark aminoacid number position of the domains at the top for Drosophila
and below for the human homolog. Some of the described roles for the domains in
humans are listed below (Toba and White, 2008), (Fukao et al., 2009). B) Aminoacid
sequence alignment of Drosophila elav and human HuR and HuD proteins showing a
very high conservation particularly in the RRM domains. C) Ribbon representation
of the structure of RRM 1 and 2 making contacts with human c-fos ARE RNA
molecule (Figure taken from (Wang and Hall, 2001a).
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domain interacts directly with eIF4A and the hinge binds polyA sequences (Fukao
et al., 2009) (Figure 4.1). The RRM domains of the Drosophila and human Elav
proteins are very well conserved (Fig 4.1B), opening the possibility of Drosophila
homolog interacting with the translation machinery. The hinge, however, shows less
conservation between the Drosophila homolog and HuD, reducing the probability of
any role of Drosophila Elav in translation.
In the interaction between RNA and proteins, secondary structure of the RNA
is crucial. Studies using computational RNA secondary predictions have been able
to find common sequences and structures used by proteins to identify their targets
(Kazan et al., 2010), (Li et al., 2010), (Mauger et al., 2013), (Dieterich and Stadler,
2013). The RBP HuR is no exception, and extensive studies have proposed a pu-
tative consensus sequence for this protein. Unlike other RNA binding proteins, the
Elav/HuR family has a very loose recognition sequence, the only condition is the
presence of A/U or U stretches (Lo´pez de Silanes et al., 2004),(Wang and Hall,
2001b).
Crystallographic experiments using the first two RRM domains of human HuD
and 11nt RNA fragments from human c-fos ARE reveal that the minimal sequence
requirements are Uracils in positions 3, 4, 5 and 8, 9 and 10 (Wang and Hall, 2001b),
(Benoit et al., 2010) (Figure 4.1C). Biochemical experiments have determined that
human HuR has similar minimal requirements. These results are supported by RNA-
immunoprecipitation experiments followed by cDNA array hybridisations (Lo´pez de
Silanes et al., 2004). RNA/protein in vitro assays (EMSAs) have demonstrated that
the HuR protein requires at least partly single stranded RNA with two stretches of
8 or 9 Uracils (Barker et al., 2012), (Benoit et al., 2010) and that substitutions for
Gs are the most disruptive mutations for interactions of HuR with target RNAs.
In previous experiments, I determined that the Elav protein has a role in the Ubx
splicing and polyadenylation. To determine the mechanism used by this protein on
Ubx RNA processing, I started a series of experiments with the aim to determine if
Elav binds directly to the Ubx RNA. The strategy used was in vitro RNA/protein
binding assays: UV crosslinking and Electrophoretic Mobility Shift Assay (EMSA)
as reported previously by Soller Lab (Soller and White, 2003). Later, I analysed
the secondary structure of the sequences tested by in vitro binding experiments to
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identify any common features. In addition, the sites were amplified and cloned using
two different lengths for each site, to test wether different nucleotide context affects
Elav binding. The Elav used was a recombinant protein produced and purified in
the Alonso Lab by Ali Mumtaz using a plasmid kindly provided by Matthias Soller
and following the procedures described in the Methods section, taken from (Soller
and White, 2003).
We used the previously described ewg sequence as a positive control for binding
and its antisense as a negative control (Soller and White, 2003). The RNA for each
sequence to test was labelled by in vitro transcription using 32P-UTP. The probes
were gel purified and quantified by scintillation method by Ambion (Methods).
4.2 Results
4.2.1 Identification of putative Elav binding sites within the
Ubx locus
The first step was to search using bioinformatics tools, potential sites within the Ubx
transcript for Elav binding sites. This work was carried out by Pedro Patraquim
and took into consideration the previously described Elav binding sites in erect wing
(Soller and White, 2003) and neuroglian transcripts (Lisbin et al., 2001), as well as
AU-rich sequences. Using this strategy, many sites were identified and subjected to
an evolutionary conservation analysis in the understanding that conservation can
indicate functionality (Figure 4.2).
The sequences used as reference from ewg are AATTTTTT and CATTTTTT
(Soller and White, 2003) and from ng are TTTTTGTTGT, TTGTTTTTTT, TTTG
TTTTT, TTTTATTTAT and TTTTTTTT (Lisbin et al., 2001). AU rich sequences
in general were also considered. The first search resulted in seventeen possible
binding sites. Phylogenetic analysis including Ubx sequences conserved in distant
drosophilids species (ultraconserved) resulted in only five ultra-conserved sites: Sites
3, 5, 8, 13 and 16 (Figure 4.2B). The Drosophila species used are: D. simulans, D.
sechelia, D. yakuba, D. erecta, D. ananassae, D. pseudooscura, D. persimilis, D.
willistoni, D. mojavensis, D. virilis and D. grimshawi.
Site 3 is located in the first intron in position 9276, 45 nt upstream the microexon
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I. This makes it a very strong candidate for an Elav binding site to control alternative
splicing. The sequence of this site is related to the erect wing site: ATTTTTT and is
perfectly conserved in all the species tested except for 3 nucleotides in D. willistoni
(Figure 4.2A and B).
Site 5 is also an interesting candidate, it is located in the third intron, at position
24134 and 68 nt downstream the microexon II. The sequence of this site is more
neuroglian like: TTTGTTTTT and it is perfeclty conserved until D. ananassae. D.
mojavensis, D. virilis and D. grimshawi show an 8 bp insertion (Figure 4.2A and
B).
Site 8 is located in the third intron, in position 32460, 8352 nt downstream mII.
Interestingly, 40 nt upstream, there is an identical sequence that is not conserved.
The sequence for both sites is TTTGTTTTT, more neuroglian-like. The conserved
site is perfectly conserved except for two nucleotides in D. willistoni and D. virilis
(Figure 4.2A and B).
Site 13 is a erect wing related sequence (AATTTTTT), perfectly conserved
among the Drosophilids except in D. willistoni. It is located in exon III in posi-
tion 53583; 21,958 nt upstream the 3’ Exon, 21,166 nt downstream the Site 8. Its
position within the largest intron of Ubx (51,476 nt), around the middle, makes it
an unlikely site for the control of the alternative splicing of mII. However, it is very
conserved and is relatively close (3,547 nt downstream) to a resplicing site, making
it an interesting site for splicing control in general (Figure 4.3).
The resplicing model of Ubx (Burnette et al., 2005) is the splicing of large introns
in two sequential steps, where an upstream resplicing site is used as an intermediary.
In the Ubx resplicing model implies that the splicing of the intron 1 and joining of
E5’ with mI regenerates a splicing donor (Figure 4.3 step 1), that can be used or
not. If it is used, then mI is spliced together with intron 2 (Figure 4.3 step 2a). If
is not used, then intron is spliced alone (Figure 4.3 step 2b). The regeneration of
the splicing site also occurs in the removal of intron 2 and joining of E5’ and mII
(Figure 4.3 step 4a and b). For the last intron, the splicing mechanism is different.
Intron 3 is extraordinarily large (51476 bp) and its splicing is divided in two steps:
an upstream splicing (or resplicing) site is used, called RP3. This site allows the
splicing of half of intron 3 and regenerates a donor site used in the second splicing
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Figure 4.2: Putative Elav binding sites in the Ubx locus. A) Representation of the
Ultrabithorax transcript, showing the exons in black boxes, the UTRs in grey boxes
and the line represents the introns. The arrow represents the start of transcrip-
tion. The arrowheads represent the positions of putative Elav binding sites and
the numbers represents the ones being tested. ng : neuroglian; ewg : erect wing. B)
Phylogenetic analysis of the putative sites showing ultra conservation in sites 3, 5,
8, 13 and 16.
reaction removing the rest of the exon (Figure 4.3 step 5 and 6.)
The last sequence (Site 16) found to be highly conserved is an AU rich sequence
in the 3’ UTR of Ubx. It is located in position 77261, 1418 nt downstream the stop
codon and 457 nt downstream the proximal polyadenylation signal. This makes it
a very interesting candidate site for polyadenylation control, following the model of
ewg and ng. This sequence has two possible Elav binding sites: TATATTTAT and
ATATATTTATCTA separated by 10 nucleotides. Secondary structure analysis of
this sequence reveals a high similarity to a sequence demonstrated to be recognised
by Elav in the Msi1 3’ UTR (Ratti et al., 2006) (Figure 4.2A and B).
Analysis of sequences suggests that the most likely factor to be involved in splic-
ing is Site 3, which is only 45 bp upstream microexon I whereas site 8 is more than
8 kb downstream microexon II and site 13 is 24 kb downstream microexon II. This
means that site 3 has a very high potential by its position, to have a role in the
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splicing decision. Site 8, being so far into the third intron, has less possibilities of
playing a role, however, we cannot exclude this possibility. Site 16 is very close to
the proximal polyadenylation site, making it a very strong candidate for an Elav
binding site involved in polyadenylation site choice (Figure 4.2).
4.2.2 Elav binds directly to Ubx RNA in EMSA experi-
ments
To test wether Elav binds Ubx directly, increasing amounts of the purified protein
(0, 200, 400 and 600 nM) were incubated with 100 pM of radiolabeled Ubx probes,
following the protocol described in (Soller and White, 2003). The probes included
the sequences of sites 3, 5, 8, 13 and 16 (relative position described in the scheme
in Figure 4.4A), also including labelled ewg as positive control and labelled ewg
antisense (ewg as) as negative control. The positive control experiment shows a rapid
shift as the concentration of Elav is increased whereas the negative control shows a
retarded shift with Elav increments. The quantifications were done using Image J
software measuring the integrated density of the free RNA signal and substracting it
to the input (as percentage) (Figure 4.4B and C). The EMSA shows a high affinity
of Elav to the ewg sequence as reported before (Soller and White, 2003). The Elav
protein clearly binds to the ewg sequences at 200 nM input (Figure 4.3 B, lane 2)
and reaches 100% saturation at the highest concentrations tested (400 and 600 nM)
(Figure 4.4B lanes 3 and 4). The ewg antisense sequence shows little RNA bound
to the Elav protein at 200 and 400 nM Elav, and only at 600 nM there is significant
RNA binding (Figure 4.4B, lane 8). These two probes behave as previously reported
(Soller and White, 2003).
Site 3 shows high affinity, with most of the RNA bound to Elav at 200 nM
protein, showing a profile similar to the ewg control (Figure 4.4B lanes 9-12). In
contrast, site 5 shows little binding at all concentrations tested, and never reaches
100% of RNA bound to Elav (Figure 4.4B lanes 13-16).
Site 8 also shows a profile similar to ewg, having most of the RNA bound to
Elav about 200 nM Elav (Figure 4.4B lanes 17-20). Site 13 shows an intermediary
binding profile, having significant % of RNA bound at 400 nM Elav, and reaching
100% RNA bound at 600 nM (Figure 4.4B lanes 21-24). Site 16 showed the lowest
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Figure 4.3: Ubx resplicing model. Exons are represented in colored boxes, black
for the 5 exon, blue for microexon I, red for microexon II and green for 3 exon.
The resplicing model is a sequential splicing model where a 5 splicing donor site is
regenerated after the previous splicing event. In this model, the first event is the
splicing of Intron 1 (1). The joining of 5 exon and mI regenerates a splicing donor
site that can be used (2a) or not (2b). The splicing of intron 3, in turn, regenerates
a splicing donor that can be used (4a) or not (4b). There is evidence that suggests
that Intron 3 itself undergoes a resplicing process: the splicing of the last intron is
achieved by two steps, the first splicing event (5) uses a recursive splicing site (RP3)
located within the intron. The use of this site (5) regenerates a splicing donor site
allowing the splicing of the second half of the intron (6). Models taken and modified
from (Hatton et al., 1998) and (Burnette et al., 2005).
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affinity, having almost no RNA binding at all concentrations tested (Figure 4.4B
lanes 25-28). The quantification of the % of RNA bound for each probe is shown in
Figure 4.4 C.
Measuring and plotting the % of bound RNA to the protein shows 100% binding
at 600 nM of Elav and shows a high percentage of binding at low Elav concentrations;
this is observed in of ewg, site 3 and site 8 probes (Figure 4.4C. The rest of the probes
do not always reach 100% binding of RNA to Elav and the percentage of binding
remains low at all the Elav concentrations tested compared to the positive control
(site 5, 13, 16 and ewg as in Figure 4.4C).
The binding curve for the antisense of ewg behaves as previously reported, show-
ing low affinity at lower Elav concentrations but reaching near 100% at the highest
Elav concentration tested (600 nM) (Figure 4.4 B and C). The EMSA experiment
allows for the observation of protein/RNA complexes of different size and we ob-
serve complexes of different sizes in the ewg, site 3 and site 8 probes. This suggests
that the Elav protein is able to assemble RNA/protein complexes with a different
number of multimers.
The probes containing the putative Elav binding sites used in these experiments
are of different size. To test if the length of the probe affects the binding properties
of the sites, a set of probes of around 150 nt were constructed and tested as described
above using recombinant Elav (Figure 4.5).
The EMSA experiments show similar results, the binding curve did not change
significantly when shorter sequences were used in the binding assays. However, using
shorter sequences we can observe some intermediate protein/RNA complexes formed
(arrows in Figure 4.5A). ewg shows at least 6 different size complexes, site 3 shows
5 and site 8 shows 7 different size complexes.
As in the previous experiments, ewg probe shows binding from 200 nM Elav
onwards, (Figure 4.5A lanes 1-4) and the ewg antisense showed binding only at 600
nM Elav (Figure 4.5A lanes 5-8). Site 3 shows RNA/protein complex forming from
200 nM Elav and an intermediate complex is observed (Figure 4.5A lanes 10-11).
Site 8 shows also a high affinity as in the experiments with the longer probes, but
now two intermediate RNA/protein intermediates are observed (arrows in Figure
4.5A, lanes 13-16). The previous experiments even with the shorter probes as with
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Figure 4.4: Elav interacts directly with Ubx RNA: A) Scheme representing Ubx
transcript. Black bars represent coding exons, gray boxes, 5’ and 3’ UTRs, lines
represent the introns. Blue ovals mark the position of the predicted Elav binding
sites. B) EMSA experiments were carried out as described in the Methods section
using 100 pM of radiolabeled RNA probes for ewg, ewg antisense, sites 3, 5, 8, 13 and
16 and 0, 200, 400 and 600 nM of recombinant Elav. Representative experiment from
three replicates. C) Quantification of the % of input RNA bound by Elav protein.
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Figure 4.5: Probe size does not affect RNA/Elav interaction. A) EMSA testing 100
pM of radiolabeled RNA probes for ewg, ewg antisense, sites 3, 8 13 and 16 at 0, 200,
400 and 600 nM of Elav, showing that the ewg, site 3 and site 8 have high affinity
for Elav. Sites 13 and 16 show even less affinity that the ewg antisense probe.
Representative experiment form three independent replicates. B) Quantification
of the % of RNA bound by recombinant Elav protein. Arrows show intermediate
RNA/protein complexes.
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sites 13 and 16 show low affinity with partial RNA binding observed at 600 nM Elav
(Figure 4.5A lanes 17-24).
In order to demonstrate that the suspected sequences are responsible for the
binding, I performed directed site mutagenesis to the probes that showed high affin-
ity for Elav binding; alternate T residues were substituted by G residues (Figure
4.6).
The mutated sites were prepared in the 150 bp probes and tested by EMSA
experiments as described. Site 3 mutated in the shorter probes shows a reduction of
affinity for Elav and loss of the intermediate RNA/Elav complex formed at 200 and
400 nM Elav observed with the site 3 wt (Figure 4.7A lanes 9-16). This suggests
that ATTTTT only site in this sequence is responsible for the formation of the
intermediate complexes. Sites 13 and 16 serve as well as the antisense of ewg, as
negative controls here. The quantification of the free RNA shows a binding curve
similar to the ewg antisense probe (Figure 4.7B).
For the site 8, mutations in site A, site B and mutants in both A and B were
tested. The mutations are described in Figure 4.6. When site 8A is mutated, there is
less RNA bound by Elav at 200 and 400 nM when compared to the wild type probe
(Figure 4.8A lanes 9-12 and 13-16, and quantification in panel B). The formation
of one of the RNA/Elav complexes is also disrupted (higher arrow in Figure 4.8A).
In contrast, when site 8B is mutated, there is also a reduction on the total RNA
bound by Elav (Figure 4.8B) and the formation of the intermediate complexes is
also disrupted. The higher molecular intermediate complex is almost absent and the
lower complex is reduced (both complexes marked with arrows). In addition, both
minor complexes marked with arrowheads are also absent when site 8B is mutated.
(Figure 4.8A).
The formation of several complexes of different molecular weight were observed
in sites 3 and 8. Figure 4.9 compares the intermediate complexes formed with
the ewg probe in previous experiments from the Soller Lab and the ones observed
in the experiments carried out in this project (Soller and White, 2005). Site 3
forms an intermediate complex and two less abundant ones, marked with arrow and
arrowheads respectively in Figure 4.9. In contrast, two intermediate complexes are
observed in site 8, and three minor ones (Figure 4.9).
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Figure 4.6: Mutagenesis of sites 3 and 8. Representation of the Ubx transcript.
Arrows mark the position of the putative Elav binding sites 3 and 8. Blue ovals
represent the binding sites and the red cross represent the binding site mutation.
Wild type sequence of sites 3 and 8 and the mutagenesis is shown below. The
putative Elav binding sites sites are underlined and the changed nucleotides are in
red.
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Figure 4.7: Mutation of potential binding site 3 partially disrupts interaction with
Elav protein. A) EMSA testing 100 pM of radiolabeled RNA probes for ewg, ewg
antisense, sites 3, 3mut, 13 and 16 for binding to Elav protein at 0, 200, 400 and
600 nM of Elav. The mutant shows an important reduction in affinity to Elav from
200 nM. Sites 13 and 16 serve as negative control together with the AS of ewg.
Representative experiment from three independent replicates. B) Quantification of
the % of RNA bound by Elav protein. The asterisk marks the complexes of higher
molecular weight.
78
Figure 4.8: Site 8 mutation partially disrupts Elav interaction. A) EMSA testing
100 pM of radiolabeled RNA probes for ewg, ewg antisense, site 8, 8A, 8B and 8AB
with recombinant Elav at 0, 200, 400 and 600 nM of Elav. Individual mutations
show an important reduction of affinity from 200 nM of Elav and when both sites
are mutated in the same probe, the affinity is reduced even more. Representative
experiment from three independent replicates. B) Quantification of the % of RNA
bound by Elav protein. The arrows mark the RNA/Elav complexes and the asterisk
marks the complexes of higher molecular weight.
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Figure 4.9: Elav and Ubx RNA forms complexes of different sizes. A) EMSA taken
from (Soller and White, 2003), Figure 3A showing the different Elav/RNA complexes
formed by Elav multimerisation. B) Representative EMSA experiments for ewg, site
3 and site 8 showing the major intermediate RNA/protein complexes marked with
arrows and less prominent complexes marked with arrowheads.
4.2.3 Elav binds directly to Ubx RNA - UV crosslink/RNAse
protection assay
To corroborate the results obtained by EMSAs, I decided to test RNA/Elav binding
using an independent method. To this end, the UV crosslink/RNAse protection
assay was performed, including the positive and negative controls , utilising probes
incorporating sites 3, 8, 13 and 16. For these experiments, radiolabeled RNA was
incubated with Elav protein in vitro, crosslinked with UV light and then RNA
was digested with RNAse A. The samples then were resolved using a standard
12% polyacrylamide gel and exposed to a phospho-imager plate overnight. The
probes that were protected by Elav binding were not digested and therefore could
be detected as a band in the gel. A non UV croslinked control was included for each
probe. First the long probes were tested and the experiments show a very evident
protected band for the ewg probe, site 3 and site 8, but no band was observed in
ewg antisense. In addition, no protected fragments were observed for sites 13 and
16 (Figure 4.10B and C). The UV crosslinks showed consistent binding of ewg and
lack of binding for its antisense sequence. Sites 3 and 8 showed also very strong
binding supporting the presence of a functional Elav binding site. Sites 13 and 16
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did not show any binding to Elav in this experiment confirming the observations
above using the EMSA approach.
The 150 bp probes were also tested also by UV crosslink and the results were
similar to the experiments carried out with the longer probes. ewg, site 3 and
8 showed a significant binding to Elav protein whereas ewg antisense and site 16
did not (Figure 4.11). The UV crosslink experiments showed a much more marked
difference between the high affinity group of sites and the low affinity group described
in the EMSA experiments. In the UV crosslinking experiments, sites 13 and 16 shows
a similar binding activity to the ewg antisense, of about 10% whereas site 3 and 8
showed a very high affinity, of around 60 and 70% respectively.
Next it was tested if the mutations in sites 3 and 8 showed a decrease in Elav
protein binding as observed by EMSAs (Figure 4.12).
The site 3 mutant showed a large reduction in affinity for Elav, with only a
weak band observed compared to the wild type probe, where a strong interaction is
observed. In the case of the site 8, mutation of site A has only a minor impact on its
affinity. Mutation of site B has a bigger impact on Elav binding but still this probe
shows high affinity for Elav. Only the double mutant shows a marked reduction of
Elav affinity (Figure 4.12).
The UV crosslink of Elav with the long and short probes demonstrated that the
affinity of Elav for the RNAs offered did not change significantly with probe length.
This suggests that under these assay conditions, the length of the probe does not
influence the binding activity, and that the sequence responsible of the binding was
not lost in the shorter sequences. These results were consistent with those obtained
previously with ewg/Elav (Soller and White, 2003). In addition, the work described
here shows that sites 3 and 8 are able to interact with Elav protein and that they
also form intermediate complexes of different sizes.
We observed that the effect of the mutation in site 3 and Elav binding is very
pronounced, decreasing the binding to Elav from 75% of the wt to 25% in the mutant
(Figure 4.12C). Interestingly, for site 8, the individual mutations did not have a very
strong effect in Elav binding, going from 60% of the wt to 55% and 50% in mutant
8A and B respectively. However, the double mutation decreases the binding to 20%
of the wild type probe. These data suggest that the Elav protein uses the two sites
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Figure 4.10: UV crosslink confirms interaction of Elav protein with Ubx mRNA.
A) Scheme of the UV crosslink strategy. The line and the yellow P represent the
radiolabelled RNA. The red figure represent Elav protein. B) Radiolabeled RNA
probes input for UV crosslink of ewg, ewg antisense, site 3, 8, 13 and 16. C) UV
crosslink showing Elav-dependent protected RNA fragments of ewg, site 3 and site 8
probes. No UV crosslink serves as a control for RNAse digestion. D) Quantification
of the protected RNA plotted as % of input showing high affinity of ewg probe and
sites 3 and 8. ewg AS, and sites 13 and 16 show a very reduced binding to Elav.
Bars represent standard error and * p≤ 0.05, ** p≤ 0.01 of the t-test in respect to
ewg.
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Figure 4.11: Probe size is not important for Elav interaction with putative Elav
binding sites. A) Input radiolabeled RNA probes for UV crosslink of ewg, ewg
antisense, site 3, 8 and 16. B) UV crosslink showing protected RNA fragments
of ewg, site 3 and site 8 probes. No UV crosslink serves as a control for RNAse
digestion. C) Quantification of the protected RNA plotted as % of input showing
Elav protection of ewg probe and sites 3 and 8 whereas ewg AS and sote 16 show
very little binding. Bars represent standard error and * p≤ 0.05, ** p≤ 0.01 of the
t-test in respect to ewg.
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Figure 4.12: Mutations of sites 3 and 8 partially decreases RNA/Elav interaction.
A) Input radiolabeled RNA probes for UV crosslink of ewg, ewg antisense, site 3,
3mutated, 16, 8, 8A, 8B, 8AB. B) UV crosslink showing Elav-dependent protected
RNA fragments of ewg, site 3 and site 8 probes. No UV crosslink serves as a control
for RNAse digestion. C) Quantification of the protected RNA plotted as % of input.
Bars represent standard error and * p≤ 0.05, ** p≤ 0.01 of the t-test in respect to
ewg.
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for an effective recognition of the site. This is as expected as it is the case for the
Elav binding site in ewg (Soller and White, 2003).
The other sites tested show a very low affinity for Elav. However, site 13 shows
the formation of an intermediate complex, suggesting that it might need another
factor to be able to be recognised by Elav. Site 16 showed the lowest affinity among
the sites tested. However, since recombinant purified protein was used here, we
cannot discard the possibility of the need of a third partner for this interaction to
occur. Supporting this possibility, the two putative Elav binding sites in the site 16
sequence is separated by a predicted polypyrimidine tract binding protein (PTB)
binding site (Shen et al., 2004).
4.2.4 Role of RNA secondary structure in Elav binding
Previous experiments demonstrated that the accessibility of the putative binding
site for protein has a very important role in the RNA binding protein interaction
to its target (Li et al., 2010). Moreover, clustering of the putative binding sites
within the secondary structure of a transcript increases the affinity of RNA binding
proteins.
Ubx is not an exception here and the secondary structure of its transcript has
been analysed by other members of the Alonso Lab (Patraquim et al., 2011). The
RNAfold tool was used in order to identify potential secondary structure features
within the sequences studied here by biochemical experiments. The ewg control
sequence forms a predicted secondary structure with loops exposing the putative
Elav binding sequence, marked with a red square in Figure 4.13. This particular
array is very efficient in the recognition of Elav, as already demonstrated above by
UV crosslink and EMSA analysis. This array presents three loops, two of them
close together and the third a bit more distant. However, the predicted structure
produced by the ewg antisense also presents three loops exposing AU rich sequences.
The AU rich stretches do not have exactly the same sequence but they still form the
loops possibly explaining why the antisense probe is able to bind Elav when used
at high concentrations. In this array, there are two loops close together and a third
one further away. This particular structure is demonstrated to have a very reduced
affinity for Elav as demonstrated by the UV crosslink and EMSA experiments. This
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is probably due to the longer distance of the third loop in respect to the other two
loops, compared to what is predicted for the wt.
A table with the secondary structure observations is shown below:
Site Sequence identity WT structure Affinity Mutant structure Affinity
3 ewg like loop High stem/loop Low
5 neuroglian like stem Low nt nt
8A neuroglian like stem/loop High loop High
8B neuroglian like stem/loop High stem/loop High
13 ewg like loop Low nt nt
16 AU rich stem Low nt nt
The site 3 structure is predicted to have a very big loop in the middle of the
sequence completely exposing the putative Elav binding site that has been demon-
strated to have high affinity for Elav. This structure is similar to the one reported
in (Ratti et al., 2006) suggesting that the structure is conserved. The mutation of
the putative binding site 3 would be predicted to disrupt the big loop and separate
the putative binding site in the loop from the stem next to it. This rearrangement
demonstrated to partially disrupt Elav recognition to this putative sequence (Figure
4.7).
The predicted structure of site 8 RNA shows a big central loop and a two long
stem loop structures. The conserved putative binding site (A) is located at the
end of the second long stem loop structure whereas the non-conserved site (B) is
located between the central loop and the first stem. Mutation of the conserved
putative binding site is predicted to disrupt the stem loop into a bigger terminal
loop. This change in structure was demonstrated to have little effect in the affinity
for Elav, probably because the putative binding site is still exposed. Intriguingly,
mutation of the non conserved site (B) is predicted to have a substantial effect on
secondary structure, yet this does not affect Elav binding to any great degree. This
might be due to the fact that the putative Elav binding sites remain exposed in
loops. Mutation of both sites prediction demonstrated to have a very big effect on
the affinity to Elav. The secondary structure prediction shows that the mutations
allow non-conserved site (B) to remain in a stem loop structure but it disrupts the
secondary structure of the conserved site (A), which might explain the dramatic
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reduction of affinity for Elav.
Predictions indicate that site 13 secondary structure also presents the putative
Elav binding site in a loop. However, this site showed a low affinity for Elav. This
result is intriguing because the loop structure where the site 13 lies is very similar
to the one in site 3 that showed high affinity to Elav. It is probable that the
vicinity of the small stem loop structure next to the putative site 13 blocks Elav
access. Another possibility is that this particular site needs additional sequences
for an effective binding or an Elav ligand is required. Site 16 contains two putative
Elav binding sites separated only by 10 nt and in the predicted secondary structure,
they are located in two adjacent stem loop structures. The sequences themselves
are located within the stems, not the loops. This might explain the extremely low
affinity for Elav that they showed in the biochemical experiments shown in this
chapter. This secondary structure is observed to form independently of the size of
the sequence used for RNA secondary structure predictions: from 150 nt as in this
case or the whole Ubx transcript (Patraquim et al., 2011).
4.3 Discussion
With the experiments described in this chapter, it has been possible to identify
two sequences that are specifically recognised and bound by Elav protein in vitro.
The sites are located within intronic sequences and could potentially affect deci-
sions on splicing site use in vivo. The experiments demonstrated that among the
sites tested, site 3 and 8 (Figure 4.5) have a very high affinity for Elav and are
able to form RNA/protein complexes of different size. Site 3 has only one puta-
tive Elav binding site that under the conditions of the EMSA and UV crosslink
experiments employed here, is sufficient to mediate Elav recognition and binding
with high affinity. This site shows a decrease of affinity for Elav when mutated, but
does not abolish binding altogether. It is possible that other sequences around it
help to stabilise the complex. There are a few A(T)4-5 sequences upstream of the
conserved and tested site that could play a role, as demonstrated in the case of site
8. It would be interesting to test these other sites and mutate them to see if the
interaction with Elav is completely abolished. In the EMSA experiments using 150
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Figure 4.13: RNA secondary structure is important for Elav recognition. Predicted
secondary structures generated using the RNAfold tool for the putative Elav binding
sites and their respective mutations used in this work. The putative binding sites
are marked with a red square.
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bp probes, an intermediate RNA/Elav complex was observed at 200 and 400 nM
Elav which disappear when this site is mutated. This suggests that the site might be
important for Elav multimerisation. Previous studies have demonstrated that Elav
multimerisation by RRM3 is mediated partially by RNA (Toba and White, 2008).
The other site found to have a strong affinity to Elav using EMSA and UV
crosslink experiments is site 8. This sequence has two putative Elav binding sites,
one identified by its ultra conservation among Drosophilids and another one iden-
tified by having the exact same sequence. The two sites are relatively close, only
35 nt apart. Both sites demonstrate similar affinity for Elav; when only one of the
sites is mutated, the affinity is reduced around 5-10% when the sites are mutated
individually. However, this affinity is greatly reduced about 75% when the two sites
are mutated (Figure 4.12C).
When we look more detailed at the affinity of binding of site 8 for Elav we
observed the formation of multiple intermediary complexes of different size. These
are still present in the individual mutations but are less stable in the double mutant.
Site 8 produces two abundant intermediates at 200 and 400 nM (arrows in Figure
4.8A), which are reduced at 600 nM when all the RNA probe is sequestered in the
highest weight complex (asterisk). In the individual mutants, the lower molecular
weight complex remans equally (8B) or is even more abundant (8A) compared to
the wild type. In contrast, the higher molecular weight complex decreases in both
individual mutants and almost disappears in the double mutant.
The other three sites tested, site 5, 13 and 16 (Figure 4.4 and 4.10) showed low
affinity in both UV crosslink and EMSA experiments, and site 5 was not tested fur-
ther because it showed the lowest affinity among the sites within introns. Predicted
secondary structure of this site shows the putative binding site within a stem (data
not shown). Site 16 showed the lowest binding ability among all the sites tested but
we further tested as negative control for the rest of the experiments, with site 13.
Interestingly, site 13 showed the formation of a very weak intermediate complex at
400 nM Elav in all experiments, suggesting that the site might be able to interact
very weakly with Elav or it might need the presence of another factor. This hy-
pothesis could be tested using nuclear extracts instead of purified recombinant Elav
alone, allowing its association with potential RNA binding facilitators. This site
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could be very interesting considering the resplicing model of Ubx (Burnette et al.,
2005). Resplicing or recursive splicing occurs in the splicing of very long introns and
whose splicing is more likely to occur alongside transcription. It uses intermediary
splice sites that regenerate a 5’ splice site that will be use in the next splicing event
(Hatton et al., 1998), (Black, 2003), (Kandul and Noor, 2009).
The Ubx has very long introns and a resplicing mechanism has been described
where the splicing of the first intron and joining of 5’ exon and mI regenerates a 5’
splice site that can be used for mI exclusion in a subsequent splicing event. With this
model, the formation of all the splicing isoforms are explained (Hatton et al., 1998)
(Figure 4.3). However, the third intron is particularly long and around the middle,
there is one resplicing site named RP3. This forms intermediate lariats in in vitro
experiments, suggesting that it is used for the complete removal of the third intron
(Hatton et al., 1998). In this context, the site 13 could be an important site for the
recognition and function of this resplicing site together with members of the splicing
machinery or other RNA binding proteins. Very early evidence of the possible in
vivo use of this site was provided when sequencing cDNAs from different sources
first identified the splicing isoforms of Ubx. Welcome Bender’s group identified five
splicing isoforms of Ubx : Ia, Ib, IIa, IIb and IVa plus another one termed ”class 4”
which consisted in the 5’ exon, mI, mII and a new 62 bp exon that maps at around
the middle of intron III. The position of this new 3’ exon maps around the RP3 site,
probably resulting from a failed resplicing event (O’Connor et al., 1988).
Site 16 showed the lowest affinity in all the experiments described in this chapter.
However, the ten nucleotides that separate the two potential binding sites contains a
predicted mammalian PTB binding site. It is possible that PTB, or another factor,
is necessary for the proper recognition of this site by Elav, and that it is actually
required for polyadenylation site choice. Previous experiments demonstrated that
the putative binding sequence for an RBP is preferentially recognised if it is accessi-
ble (Li et al., 2010). In the experiments described here, this is confirmed. The sites
that showed the highest affinity to Elav contain the putative binding site completely
or partially within a loop. However, previous studies have revealed that the HuR
protein in mammals also recognises binding sites in both loop and stem (Lo´pez de
Silanes et al., 2004). This might seem contradictory and the results in this work
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show high affinity binding sites in both circumstances: within a loop and partially
paired in a stem (ewg, Site 3 and 8A). In contrast, site 8B is partially paired in
a stem and partially accessible in a loop. However, the mutation in site 8B that
maintains most of the binding ability of this sequence might be due to the fact that
the binding site A remains in an open loop, highly accessible to Elav and that site
8B itself remains partially accessible.
Analysing the common features of the sequences analysed by biochemistry ex-
periments and secondary structure predictions, it is difficult to assign a particular
feature that predicts, Elav recognition with high affinity. However, it is clear that
the sites with higher affinity are located within loops (ewg, site 3, site 8) and the
disruption of the loop disrupts RNA/Elav affinity, as demonstrated in the site 3
mutant and particularly in the double mutant of site 8. However, being located in
a loop does not guarantee high affinity for Elav (ewg antisense, site 13). It might
be that the structure within the close vicinity is also important for the accessibility
of the Elav protein, or other factors needed to stabilise the interaction.
The initial observation shows that Elav is necessary but it is not the only factor
involved as we still see all of the Ubx splicing isoforms formed in the mutant. This
suggests that there are more factors interacting and giving the final splicing output.
Which are those factors and how they interact remain unknown. However, some
lines of evidence suggest that many RBPs provide a mechanism of fine tuning of
alternative splicing or polyadenylation, providing with a certain balance of isoforms
produced. Maybe a small change on this balance of isoforms is enough for particular
responses (Kalsotra et al., 2010).
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Chapter 5
Other factors affecting
Ultrabithorax mRNA processing
5.1 Introduction
In the previous chapters I have described the role of Elav in the processing of Ubx
mRNA, specifically in exon inclusion and polyadenylation site selection during em-
bryonic development. I demonstrated a direct interaction between Elav protein and
intronic sequence elements in vitro that could mediate splice site choice in the Ubx
mRNA. The results obtained showed that the absence of Elav protein results in a
change in the proportion of Ubx isoforms produced but does not abolish the pro-
duction of specific isoforms. A possible explanation is that the experiments were
carried out using whole embryos containing RNA from epidermal and endodermal
tissue, adding noise to the samples. Another possibility is that there are more
post-transcriptional regulators acting in parallel to Elav controlling Ubx alternative
splicing and polyadenylation. The objective of the present chapter is to test this
second hypothesis.
The final splicing and polyadenylation patterns of many transcripts are deter-
mined by a combination of protein factors (Burnette et al., 1999), (Smith and
Valca´rcel, 2000). The relative levels of factors in the cell acts as a ”cellular code” to
establish specific splicing and polyadenylation patterns (Smith and Valca´rcel, 2000).
To start elucidating the ”cellular code” that controls Ubx splicing and polyadeny-
lation during development, I looked for candidate protein regulators of Ubx RNA
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processing suggested from previous work. The aim was to investigate if other fac-
tors play a role in the regulation of Ubx mRNA splicing and polyadenylation during
embryonic development. I initially focussed on factors with evidence to suggest that
they affect some aspect of RNA processing.
5.1.1 Other factors reported to affect Ubx RNA processing
Ubx has been an excellent model to study how alternative splicing is controlled
because it produces a number of splicing and polyadenylation isoforms during de-
velopment; it offers a simple and sensitive system to screen for regulatory factors.
The various Ubx isoforms have different abilities to rescue a Ubx phenotype in the
haltere, so a sensitised genetic background can be used to screen for factors affect-
ing the balance of isoforms, which will therefore impact the degree of the phenotype
rescue (Burnette et al., 1999).
A deficiency screen for factors that allow the rescue of Ubx phenotype (haltere to
wing transformation in adults) has previously identified Virilizer (Vir), Female lethal
(2)d (Fl(2)d), Croocked neck (Crn) and (Heterogeneous nuclear ribonucleoprotein
at 27C)(Hrb27c) genes. These four factors affected Ubx splicing during larval and
adult stages (Burnette et al., 1999). As I have seen for elav mutants, virilizer, fl(2)d,
crn and hrb27c mutants were found to affect the relative levels of isoforms; however,
all the isoforms are still present. This suggests that a single factor is insufficient to
make a splicing decision rather, this decision is made by a combination of factors.
How many more factors are involved in the Ubx splicing decision? What is the role
of each of the factors involved? Do the factors affect both microexons the same way?
What about other RNA processing events? In the previous chapters, I described
how a single RBP is able to affect splicing and polyadenylation events. Do virilizer,
fl(2)d, crn and hrb27c mutants affect polyadenylation site choice in Ubx too? Do
other factors affect splicing and polyadenylation? Do factors affecting transcription
events also play a role in splicing and polyadenylation of the Ubx RNA molecule? To
address these questions, I have explored the effect on splicing and polyadenylation
of Ubx by a number Drosophila factors, including: Crn, Hrb27c and Fl(2)d. I also
wanted to look at the relationship between transcription and post-transcriptional
RNA processing, so I also looked at Brahma and Mi-2 chromatin remodelling factors.
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Figure 5.1: Panel of candidate Ubx mRNA processing regulators. A-H) Schemes
showing the domain organisation of the candidate factors in boxes. A) Crn protein
domain organisation: TPR, Tetratricopeptide repeat domain; HAT, Half a TPR
domain. B) Hrb27c protein domain organisation: RRM, RNA recognition motif.
C) fi(2)d protein domain organisation: H/Q rich domain, histidine and glutamine
rich domain. D) Brahma protein domain organisation: QLQ, glutamine and leucine
rich domain involved in protein/protein interaction; HSA, helicase and SANT do-
main related domain; BRK, associated to Brm domain; DEAD box helicase domain;
HELICc is a conserved C-terminal domain of two super families of helicases; Brm,
Bromodomain. E) Mi-2 protein domain organisation: CHDNT and CHDCT2 are
PHD/RING finger and chromodomain associated domains; RING, Really Interest-
ing New Gene zinc finger domain; CHR or CHROMO, Chromatin Organisation
MOdifier domain; SNF2, domain from SNF2 protein. F) PS protein domain or-
ganisation: KH-II, heterogeneous nuclear ribonucleoprotein (hnRNP) K homology
domain, involved in RNA recognition. G) Zn72D protein domain organisation: zf,
ZfC2H2-zinc finger double stranded RNA binding domain; DZF, Nucleotidyl trans-
ferase superfamily domain. H) Su(f) protein domain orgnanisation: HAT, half a
TPR; Suf, domain from the Su(f) family.
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Three other RNA processing factors were also tested: Pasilla, Zn72D (Zinc-finger
protein at 72D) and Su(f) (Suppressor of forked).
Crn
crooked-neck gene is located in the X chromosome (CG3193). It was identified in a
screen for genes important for development that produced embryos that were twisted
along the longitudinal axis (Perrimon et al., 1984). Crn protein is 702 aa containing
a tetratrico peptide repeat (TPR) motif, involved in cell cycle progression in yeast
(Zhang et al., 1991) (Figure 5.1A). However, its function in the cell cycle has not been
described in Drosophila. More recent studies have revealed that Crn is expressed
ubiquitously in Drosophila embryos, in cell nuclei and enriched in ”speckles”. These
foci have been described to serve as storage for splicing factors,(Spector and Lamond,
2011) suggesting that Crn could have a direct role in splicing. Crn fractionates with
snRNPs in sucrose gradients, supporting the existence of a splicing multiprotein
complex containing Crn (Raisin-Tani and Le´opold, 2002), moreover, Crn protein
promotes the assembly of the spliceosome (Wang et al., 2003).
Its human homolog (Hcrn) has been demonstrated to associate with splicing
complexes and in vitro splicing is compromised if Hcrn is immunodepleted from the
nuclear extract (Chung et al., 2002). Crn in Drosophila is required for germ cell
viability as well (Perrimon et al., 1984). Interestingly, despite the ubiquitous distri-
bution of Crn, Drosophila deletion mutants have strong phenotypes in the CNS and
gut (Eberl and Hilliker, 1988). In agreement with this, Crn is present in the cyto-
plasm and affects the development of glial cells. Crn interacts with HOW (held out
wings) to mediate migration and ensheathment of peripheral axons (Salecker, 2006).
Crn is not predicted to bind RNA directly, but HOW does. Together Crn and HOW
regulate the alternative splicing of nervana2 (nrv2) (Na/K ATPase beta subunit)
and neurexinIV (nrxIV), which is transmembrane cell-surface protein. The resulting
proteins are components of the glial septate junctions (Salecker, 2006), (Edenfeld
et al., 2006). This suggests an important role of Crn in the CNS, modulating the
splicing of a variety of targets, maybe including Ubx. If Crn affects Ubx mRNA pro-
cessing within the CNS, the determination of cell lineages might be compromised
since Ubx is important in the determination of some neuronal lineages, such as NB-1
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(Rogulja-ortmann and Technau, 2008). crn mutants have been shown to affect Ubx
by modulating the inclusion of mI exon, generating less isoform I and more isoform
II (Burnette et al., 1999).
Hrb27c
Heterogeneous nuclear ribonucleoprotein at 27C (CG10377) is located in the left
arm of chromosome 2. It is also known as Hrp48, p50, RRM7, Hrb27-c. It was
first described in the tissue-specific regulation of P- element transposase third-IVS3
intron splicing. It binds a pseudo-5’ splice site within the exon regulatory element
to reduce the accessibility of real 5’ SS to splicing machinery (Siebel et al., 1994).
The Hrb27c protein contains two N- terminal RBD-type (RNA Binding Domain)
RNA-binding domains and a glycine-rich carboxyl-terminal domain (Matunis et al.,
1992) (Figure 5.1B). It is one of the most abundant hnRNP proteins in Drosophila
(Blanchette et al., 2005), (Blanchette et al., 2009). These proteins have been shown
to associate with the majority of nascent transcripts (Hammond et al., 1997). More
recently, it has been shown that Hrb27c promotes grk localization and affects embry-
onic DV patterning, through direct interaction (RNA-independent) with otu protein
(Ovarian tumor) to aid RNA localization. Hrb27c interacts with Squid in an RNA
dependent manner resulting in the proper localization of grk mRNA (Goodrich et al.,
2004). Some evidence suggests that Hrb27c plays a role in translational regulation
of osk RNA, in a similar way to grk regulation (Goodrich et al., 2004). Hrb27c
appears to have a role in chromosome dispersion, as polytene chromosomes in nurse
cell fail to disperse in a Hrb27c mutant (Goodrich et al., 2004).
Acting on alternative splicing, it has been previously shown that Hrb27c affects
the inclusion of both Ubx microexons in Drosophila larvae and adults. In Hrb27c
mutants the level of Ubx isoforms II and IV are increased whilst I is reduced (Bur-
nette et al., 1999).
fl(2)d
Female lethal d (CG6315) is located in the right arm of chromosome 2. It was first
described as a factor that interacts with Sxl. It is involved in sex determination
and X chromosome dosage compensation (Penalva et al., 2000). Fl(2)d is a 539 aa
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protein, with no structural domain characteristic of proteins involved in splicing in its
primary sequence. The amino- terminal region is a HQ-rich domain (Figure 5.1C).
It also has a glutamine-rich region and a putative dimerization domain (Penalva
et al., 2000), (Ortega et al., 2003). Fl(2)d is also needed for a vital process which
is independent of Sxl (Granadino et al., 1990). The homozygote mutant is lethal in
females and males, but the precise role of Fl(2)d is unknown. It is unlikely that it
is a member of the core splicing machinery because the mutant is not cell lethal,
when it is embryonic lethal. It could have a role in directing the correct splicing of
a factor needed for development, independently of the sex determination pathway
(Penalva et al., 2000). Interestingly, in a screen looking for interactors with Ubx,
significant reductions of mI and mII inclusion were observed in larvae and adults
with mutations in this factor (Burnette et al., 1999).
5.1.2 Chromatin structure in mRNA processing
Two of the proteins that can be associated to the Swi/SNF complex have been chosen
to test the role of chromatin regulation in splicing and polyadenylation regulation:
Brahma and Mi-2. Brahma protein has been shown to affect alternative splicing
by modulating the transcription rate of RNApolII. Mi-2 protein has been shown to
affect Ubx expression by interacting with Polycomb. I sought to investigate if Ubx
splicing is affected in the absence of these two factors.
Brahma
Located in the left arm of the 3rd chromosome, (CG5942) Brahma (Brn) was first
described in a screen looking for factors that suppress or enhance mutations of
homeotic alleles of the Antenapaedia and Polycomb groups (Tamkun et al., 1992).
Mutations in the brm locus suppressed the production of extra sex combs (Polycomb
phenotype) and antenna to leg transformation (Antenapaedia phenotype). It is a
1638 amino acid protein, with a structure related to the SNF2/SWI2 (mating-type
switch/sucrose nonfermenting) yeast transcription activator. It contains a conserved
bromodomain at its C-terminus (Tamkun et al., 1992) (Figure 5.1D). It belongs to
the trithorax group (Kennison and Tamkun, 1988) and is part of a chromatin remod-
elling complex, interacts with U1 and U5 snRNPs and with the RNA polymerase II,
97
slowing its rate of transcription affecting exon inclusion in general. The presence of
Brahma in the transcriptional complex leads to a slower transcription, allowing the
coexistence and competition of the splicing sites, therefore, promoting exon inclusion
(Batsche´ et al., 2006). It also interacts with splicing factors to regulate alternative
splicing. In larval stages and S2 cells, depletion of Brahma affects the splicing of
lola and Gpdh transcripts (Batsche´ et al., 2006), (Waldholm et al., 2011). hBrm
regulates the alternative splicing of the CD44 pre-mRNA in human cells by decreas-
ing the elongation rate of RNAP II (Waldholm et al., 2011). Drosophila Brm is
a nuclear protein, expressed ubiquitously, in early embryogenesis and is maternally
encoded. Further to its interaction with Polycomb and Antenapaedia, it has been
shown that it interacts with Ubx in combination with trithorax. A brm mutant
will increase a Ubx mutant phenotype, suggesting a role for Brahma activating Ubx
gene (Tamkun et al., 1992). However, no effect on Ubx RNA processing has been
described.
A more detailed study of Brahma function, has found that this factor associates
with open chromatin, which is actively transcribed and moreover, that Brm is es-
sential for global transcription (Armstrong et al., 2002).
The interaction with chromatin depends on the bromodomain and is direct.
However, direct interaction of Brm with the RNAPol-II has not been reported.
hBrm ATPase activities are stimulated to the same extent by nucleosomes and
naked DNA.
Mi-2
Gene located in the left arm of the 3rd chromosome (CG8103), Mi-2 was orig-
inally described in mammals as a dermatomyositis specific auto antigen (Seelig
et al., 1995). The Mi-2 is a 1983 aa protein that contains two PHD-zinc-finger
domains, two chromo-domains and a a SWI2/SNF2-type helicase/ATPase domain
(Figure 5.1E) (Seelig et al., 1995), (Khattak et al., 2002). It has been described as
a ATP-dependent chromatin remodelling factor and participates in the repression
of Hunchback and Polycomb (Kehle, 1998), (Fasulo et al., 2012). Mi-2 interacts
with Polycomb to repress the expression of Ubx. Mutations in Mi-2 alone have no
evident Ubx phenotype, and the expression of Ubx and Abdominal B is normal in
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Mi-2 mutant embryos, probably due to the maternal contribution of Mi-2. Mi-2 is
expressed strongly in early embryogenesis, less strongly in late embryos and weakly
in larvae; it is also expressed strongly in ovaries (Kehle, 1998).
Mi-2 is a component of a chromatin remodelling complex whose ATPase is prefer-
entially stimulated by nucleosomes and modifies chromatin through histone deacety-
lation to repress transcription and (Brehm et al., 2000). The sites of deacetylation
are targeted but the mechanism remains unknown.
Pasilla
Located in the right arm of the 3rd chromosome (CG42670), Pasilla encodes the
Drosophila orthologue of the mammalian Nova (Neuro-oncological ventral antigen)
protein, which was first described as a target protein of the human autoimmune dis-
order POMA (paraneo- plastic opsoclonusmyoclonus ataxia) (Seshaiah et al., 2001).
It was one of the first neuronal specific splicing factors studied and it is involved
in neuronal survival, migration and splicing of transcripts with dendritic functions
(Norris and Calarco, 2012). Pasilla protein contains three conserved KH RNA bind-
ing domains (Figure 5.1F). The human homologue, Nova, promotes the inclusion of
the exon e24a and represses the inclusion of exon e31a in the P-type Calcium chan-
nel mRNA in the brain, demonstrating that the same factor has both enhancing and
repressing capabilities depending on the position of the binding site (Allen and Lip-
scombe, 2010). The binding site of this factor has been well characterised (YCAY)
(Licatalosi et al., 2008). Studies using high - throughput sequencing of crosslinked
immuno-precipitation with Nova antibody have revealed a large number of targets,
confirming that the position of binding sites determines the effect on splicing, gen-
erating a sort of RNA ”map”. Nova binding elements located in regions upstream
of exons act as repressor sites whereas elements located downstream the exons act
as activators of splicing.
The data is so consistent that it provides the grounds to predict outcome of Nova
action de novo. Interestingly, the study found a large number of interactions located
at the 3’ UTR of transcripts, revealing a role of Nova in alternative polyadenylation
in the mouse brain (Licatalosi et al., 2008). Nova could provide a direct link between
alternative splicing and polyadenylation in the brain. In Drosophila, Pasilla is highly
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expressed in larval salivary glands and has been implicated in salivary gland secretion
(Seshaiah et al., 2001). Interestingly, it has been demonstrated that the RNA map
described in mammals is very well conserved to Pasilla in Drosophila (Brooks et al.,
2011), suggesting that the mechanism used in both systems is similar. Pasilla is
not maternally encoded but embryonic expression starts at stage 6 at the endoderm
and at later stages it is expressed in the hindgut and midgut, salivary glands and
fat body (Tomancak et al., 2007).
Zn72D
Zinc-finger protein at 72D (CG5215), is located in the left arm of chromosome 3.
It has three C2H2 zinc fingers, a DZF domain (Figure 5.1G) Zn72D is a protein
involved in the sex determination pathway in Drosophila, needed for the splicing of
the maleless (mle) transcript, which encodes an essential subunit of the MSL (Male
Specific Lethal) complex in coordination with Belle DEAD box helicase(Worringer
and Panning, 2007), (Worringer et al., 2009). However, Zn72D is also required
for the viability of both sexes. Consistent with this, Zn72D co-localises with elon-
gating RNA polymerase, potentially controlling splicing indirectly by modulating
transcription speed (Worringer and Panning, 2007). Additional to this role, it has
been suggested that recruitment of Zn72D to the mle transcript has an effect on
translation levels, (Worringer et al., 2009). Zn72D protein is localised to the nu-
cleus and cytoplasm in humans. ZFR (homolog of Zn72D) is localised in neuronal
granules where it interacts with and localises staufen262 to the cytoplasm, presum-
ably affecting its translation rates (Worringer et al., 2009). Zn72D is maternally
encoded and is expressed ubiquitously at early embryonic stages. At later stages
its expression is restricted to the CNS, PNS, hindgut and midgut (Tomancak et al.,
2007).
Su(f)
Suppressor of forked, (CG17170) is located in the X chromosome. It was first de-
scribed as a protein that suppresses the bristle phenotype produced by some of the
alleles at the forked locus (Dudickz et al., 1974). It is the Drosophila homologue
of CstF-77, a subunit of human cleavage stimulation factor (CstF). It is also con-
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served to yeast, suggesting that its role in 3’ UTR processing is conserved (Takagaki,
Yoshio ; Manley, 1994). The Su(f) protein has a proline-rich domain a HAT, hald
TPR domain (Figure 5.1H). Su(f) is required for the cleavage of pre-mRNA during
mRNA 3’ end formation. It also interacts in vitro with Drosophila CstF-64, CstF-
50, and itself. Su(f) activity must be optimal for regulated utilisation of poly(A)
sites (Benoit et al., 2002).
Because Su(f) is a factor of the general cleavage and polyadenylation machin-
ery, it is expressed ubiquitously during embryonic stages, and is maternally encoded
(Tomancak et al., 2007). Su(f) is required for larval and pupal stages; in the adults
is needed for oogenesis and clones in imaginal discs lacking Su(f) show apoptosis
and disruption of pattern determination (Mitchelson et al., 1993). Early evidence
suggests that Su(f) also plays a role in RNA stability, as its mutant leads to accumu-
lation of f (forked) RNAs in a gypsy insertion in f locus, and also of an heterologous
RNA (Mitchelson et al., 1993).
5.2 Results
5.2.1 Normal expression of candidate factors during Drosophila
embryonic development
To test the effect of mutating the candidate factors in Ubx mRNA processing I
first investigated their normal expression levels at embryonic stages 15 and 17.
For this, I did a search in RNA-seq data from modENCODE available in FlyBase
(http://flybase.org/). From this collection I recovered the RPKM (Reads Per Kilo-
base of transcript per Million mapped reads) count for each gene at stages 14-16
and 16-18 hAEL, which given in the table below:
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Candidate factor Stage 14-16 hAEL Stage 16-18 hAEL
brm 53 36
mi-2 101 71
ps 26 78
crn 23 19
zn72D 23 16
fl(2)d 41 36
hrb27c 62 59
su(f) 18 14
The RNAseq data shows that all of the factors I planned to test are expressed
at the stages I am interested in this study. In general, earlier stages show higher
levels of expression that later stages, except for ps, which shows much higher levels
at stage 16-18 hAEL.
brahma, su(f), zn72D, hrb27c, fl(2)d and mi-2 are maternally provided and
show higher expression levels at earlier stages, being mi-2 the factor with highest
expression. crn and ps are not maternally encoded but crn expression is slightly
higher at stage 14-16 hAEL.
5.2.2 Checking of mutants for the candidate factors
Next I confirmed the mutants for the selected factors. The collection of mutant
stocks for the candidate factors is a mixture of mutation types. Four of them (zn72D,
ps, fl(2)d and hrb27c) are P element insertions (Figure 5.2 and 5.3) , crn and brm
are point mutations whose exact positions are unknown (Figure 5.4), su(f) is a
deletion and mi-2 is an insertion (Figure 5.5). The P-element insertion mutants
were genotypified by PCR using primers that map outside the insertion and inside
the insertion (Figure 5.2 and 5.3). Genomic DNA was extracted from whole adults
(two males and two females) and wild type flies were used as control. The ribosomal
protein L32 (also known as rp49 ) was used as a control for RNA input for PCR.
The four mutations by insertion produced an amplicon when a forward primer
before the insertion and a reverse primer inside the inserted element were used in
genomic PCR, and no band was observed in the wild type control (Figure 5.2 and
5.3).
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The same strategy was used for the su(f) mutant, using a forward primer before
the deletion and a reverse primer inside the deletion. The heterozygote showed a
reduction of near 50% relative to rp49 signal (Figure 5.4A). mi-2, crn and brahma
mutations were not possible to characterise by genomic PCR (Figure 5.4B, 5.5).
zn72D mutant: The mutant zn72D [BG02677] is a P element (PGT1) insertion
at the beginning of the transcript, interrupting the ORF. The BDSC stock 21586
(y[1]w[67c23]; Pw[+mC]=GSV7GS21586/SM1) was balanced with a Cyo chromo-
some that expresses GFP under a Twist promoter (Figure 5.2A).
pasilla mutant: The pasilla mutant ps [10615] is a P element (PPZ) insertion at
approximate the center of the gene (Figure 5.2B). The BDSC 10236 (Pry[+t7.2]=PZps[10615]
ry[506]/TM3, ry[RK] Sb[1] Ser[1]) stock was balanced with TM3 with a Twist-GFP
(Figure 5.2B)
hrb27c mutant: hrb27c[DG19705] is a P element (PwHy) insertion at the start
of transcription, interrupting the ORF (Figure 5.2C). The BDSC stock 21702 (y[1]
w[67c23]; Py[+t7.7] w[+mC]=wHyhrb27c[DG19705]/SM6a) was balanced with a
CyO chromosome with GFP expression under a Twist promoter (Figure 5.3A).
fl(2)d mutant: The mutant fl(2)d [DG37212] is a P element (PwHy) insertion
located at the beginning of the transcript, interrupting the ORF (Figure 5.1D). The
BDSC stock 21586 (y[1] w[67c23]; Py[+t7.7] w[+mC]=wHyfl(2)d [DG37212]/SM6a)
was balanced with a Cyo chromosome expressing GFP under Twist promoter (Figure
5.3B).
su(f) mutant: The mutant su(f)[6] is a deletion of 1kb (Figure 5.3A). The BDSC
stock 4735 (y[1] v[1] su(f)[6]/FM7a) was balanced with a FM7c chromosome that
expresses GFP under Kruppel promoter (Figure 5.4A).
mi-2 mutant: The mi-2 [4] mutant is a 4 bp insertion caused by ethyl methane-
sulfonate (Seelig et al., 1995)that creates a frameshift producing an early stop codon
(Figure 5.3B). The BDSC stock 26170 (mi-2 [4] red[1] e[4]/TM6B, Sb[1] Tb[1] ca[1])
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Figure 5.2: Geno-typification of P-element insertions in zn72D and ps mutants. A-
B) The top scheme represents the position of the insertion of the P-element in each
case. Just below is a scheme of the element inserted. Genomic DNA was extracted
for PCR using the primers in the positions marked with arrows, forward primer
before inserted element and reverse primer within the inserted element. Agarose
gels were used to resolve the PCR, wild type genomic DNA was used as negative
control and rp49 as loading control. A) zn72D mutant. B) ps mutant. Gene
representation taken from FlyBase and P-element scheme taken from (Adams and
Sekelsky, 2002).
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Figure 5.3: Geno-typification of P-element insertions in hrb27c and fl(2)d mutants.
A-B) The top scheme represents the position of the insertion of the P-element in each
case. Just below is a scheme of the element inserted. Genomic DNA was extracted
for PCR using the primers in the positions marked with arrows, forward primer
before inserted element and reverse primer within the inserted element. Agarose
gels were used to resolve the PCR, wild type genomic DNA was used as negative
control and rp49 as loading control. A) hrb27c mutant. B) fl(2)d mutant. Gene
representation taken from FlyBase and P-element scheme taken from (Adams and
Sekelsky, 2002).
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Figure 5.4: su(f) and mi-2 mutant. A-B) The top scheme represents the gene and
the position of the mutation. A) The su(f) deletion was the only one possible to
detect by genomic PCR using primers outside and inside the deletion, marked with
arrows. Agarose gel showing the amplicons produced on wild type and su(f)/FM7c
adults. Wild type flies were used as control and rp49 as loading control. B) mi-2
mutant is an insertion of 4bp at the start of the PHD-fingers domain causing a
frameshift. Scheme from (Seelig et al., 1995).
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was balanced with a TM3 balancer with GFP expression under Twist driver (Figure
5.4B).
crn mutant: The mutant used here is a point mutation caused by ethyl methane-
sulfonate (Eberl and Hilliker, 1988) (Figure 5.3C). The stock yok-EH352 from BDSC
4292 (y[1] crn[yok-EH352]/C(1)DX, y[1] f[1]/Dp(1;Y)y[2]sc) was not possible to bal-
ance with a GFP expressing chromosome.
brahma mutant The brahma mutant brm[2] has been described as a point mu-
tation at an unknown position that changes the activity of the protein but does not
affect its expression (Tamkun et al., 1992) (Figure 5.3D). Mutant embryos die before
hatching and loss of maternal protein affects oogenesis (Brizuela et al., 1994). The
BDSC stock 3619 (brm2 e5 Ca1—/ TM6b Tb Sb DfdLacZ) was balanced with a
TM3 balancer that expresses GFP under a Twist promoter.
5.2.3 Mapping the Brahma mutation
The brahma mutant was described using a mutant produced by ethyl methanesul-
fonate (brm[2]) reported by Kennison in 1988 (Kennison and Tamkun, 1988) displays
normal protein expression (Tamkun et al., 1992), however, the study claims it is not
functional suggesting a point mutation in a functional domain such as the bromod-
omain. The protein structure of the brm protein contains the bromodomain in the
carboxyl end (blue in Figure 5.5), a conserved helicase domain of the HELICc family
(purple in Figure 5.5) and a DEAD-like domain (red in Figure 5.5), also an helicase.
This three domains are the most conserved and better characterised domains within
the brahma protein so I designed primers to detect any mutation in those areas.
The sequence of the primers are enlisted in the following table:
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Oligo name sequence domain
brm.1.fw ATCAATTGCCCATGCCTTC Bromodomain
brm.1.rv TGAGTTACACTGCTCGCTGTT Bromodomain
brm.2.fw AGCGAGCAGTGTAACTCACCT HELICc
brm.2.rv AGGACCGGATCTGTATCGTG HELICc
brm.3.fw AAGATAAACTTACCGGATACAACTCC DEAD-like helicase
brm.3.rv GTGAAACAGCACAAGGACGA DEAD-like helicase
High Fidelity PCR was carried out and the PCR products were cloned in pGEMT
easy vector and sequenced. Four independent clones for each amplicon were sent to
sequence using both T7 and M13RV oligos.
The sequencing of the cloned fragments showed only a single point mutation with
the brm.1 pair of oligos corresponding near to the carboxyl end of the bromodomain,
in the BC loop: a T was substituted by a C changing the codon TCT to TCC. Both
codons code for Serine (Figure 5.5). Structure of bromodomain was taken from
(Mujtaba et al., 2007).
The silent point mutation found does not explain the lack of function of the
brahma mutant. The rest of the domains were not analysed so the mutation might
be in another region fundamental for brahma normal function.
The mutations of the candidate factors show reduction in the expression
of their proteins
.
To confirm that the stocks for the candidate factors used in this study, RT-
PCRs for each factor were carried out using cDNA from mutant embryos at stage
17 (Figure 5.6 and 5.7).
Most of the factors tested showed a marked reduction of their expression in
their corresponding mutant embryos (Figure 5.6 and 5.7). brahma did not show
significant reduction but this was not expected because the mutation still produce
protein, although the reports of the mutant claims is not functional (Tamkun et al.,
1992)(Figure 5.7C).
ps and su(f) showed a complete reduction of their expression in the mutants
(Figure 5.6B and D) whereas the crn heterozygote shows a significant reduction in
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Figure 5.5: Mapping of the brm2mutant. The protein domains are shown as coloured
boxes: light pink for QLQ domain, green for HSA, yellow for BRK, red for DEAD-
like domain, purple for HELICc domain and blue for the bromodomain. The arrows
represent the approximate position of the primers designed for sequencing. The
BRM domain structure is shown below and the position of the silent point mutation
is indicated with an arrow (Mujtaba et al., 2007).
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Figure 5.6: The mutants of the candidate factors reduce their expression. RT-PCR
using RNA extracted from homocygote mutant embryos at stage 17. Top scheme
is a representation of the transcript for each candidate factor and the primers used
for RT-PCR are marked with arrows. Agarose gels were used to resolve the bands,
wild type RNA was used as positive control and rp49 was used as loading control.
A) zn72D. B) ps. C) fl(2)d. D) su(f).
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Figure 5.7: The mutants of the candidate factors reduce their expression. RT-PCR
using RNA extracted from homocygote mutant embryos at stage 17. Top scheme
is a representation of the transcript for each candidate factor and the primers used
for RT-PCR are marked with arrows. Agarose gels were used to resolve the bands,
wild type RNA was used as positive control and rp49 was used as loading control.
A) mi-2. B) crn. C) brm. D) hrb27c.
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its expression (Figure 5.7B).
zn72D, fl(2)d and hrb27c show a substantial reduction of their expression but
not complete, due to their maternal contribution (Figure 5.6A, C and 5.7D).
5.2.4 Effects on Ubx mRNA levels
RNA binding proteins are factors that usually affect more than one aspect of RNA
metabolism, for example, transcription or degradation (Gamberi et al., 2006). To
assess if the protein factors have a role in transcription, the abundance of the Ubx
transcript was analysed by semiquantitative RT- PCR using primers that amplify
a region in the proximal 3’ UTR (Universal) (Thomsen et al., 2010) (Figure 5.8A).
For each experiment, three independent biological samples of at least 50 embryos
were used for each genotype tested, RNA was extracted and RT-PCR was carried
out as described in the Methods section.
The preliminary results presented in this chapter suggest that the factors tested
affect splicing, polyadenylation and RNA abundance of Ubx.
An interesting observation is that the effects of mutations were different at the
two developmental time points sampled. At stage 15, in general there are not major
differences between the wild type reference and the mutants for the different factors,
except for ps mutant which showed an increase in Ubx RNA and hrb27c, which show
a decrease in total Ubx levels. crn shows a statistically non significant increase of
Ubx levels. The effect of ps and crn might be related to their role in splicing or may
be an indirect effect via the processing of a factor involved in RNA stability.
The other factors show either no difference or a slight increase on mRNA levels
(Figure 5.8B and C). However, at stage 17, the effect of the factor mutants on
Ubx mRNA levels change dramatically and all of them show a marked decrease,
except for fl(2)d mutant which shows no change (Figure 5.9). brm and crn show a
statistically significant reduction of Ubx mRNA levels.
This result suggests that most of the protein factors tested here are not involved
in transcription regulation or RNA stability at stage 15. fl(2) has an impact in
earlier stages but not at later stages. This could be due to a lower expression of
the factor at stage 17. Given that fl(2) is maternally encoded, it is more strongly
expressed at earlier stages, making it possible that normally at stage 17 its role is
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Figure 5.8: Ubx mRNA levels at stage 15: RT-PCR of three independent biological
RNA samples. A) Diagram of Ubx mRNA showing the position of the primers used
for RT-PCR. B) RT-PCR of Ubx Universal region and rp49 as loading control in
each of the mutants cDNAs and wild type as control. C) Quantification of the
signal normalised with rp49 levels showing a reduction of Ubx mRNA in the hrb27c
mutant and an increase in ps mutant. Bars represent standard error and * p≤ 0.05,
** p≤ 0.01 of the t-test in respect to the wild type.
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Figure 5.9: Ubx mRNA levels at stage 17: RT-PCR of three independent biological
RNA samples A) RT-PCR of Ubx Universal region and rp49 as loading control
in each of the mutants cDNAs and wild type as control. B) Quantification of the
signal normalised to rp49 levels showing a reduction of Ubx mRNA in brm, ps, crn
mutants. Bars represent standard error and * p≤ 0.05, ** p≤ 0.01 of the t-test in
respect to the wild type.
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no longer important. Interestingly, like fl(2)d, hrb27c is also maternally provided
and has a stong effect at earlier stages, but at later stages it seems to have a be
less important effect, maybe explained by its lower levels of expression in the wild
type. The decrease in mRNA levels in the other mutants could be explained by an
RNA destabilizations due to defective RNA processing or indirect effect on tran-
scription. On the contrary, brm and crn show no effect at stage 15 (Figure 5.8) but
a statistically significant reduction of Ubx at stage 17 (Figure 5.9).
5.2.5 Effects on Ubx splicing patterns
The Ubx isoform patterns in a wild type fly change during normal development
(O’Connor et al., 1988),(Kornfeld et al., 1989), (Thomsen et al., 2010). At ear-
lier stages of development, the trend is to include both microexons, resulting in
more production of isoform I and II and less production of isoform IV. At later
stages, isoform IV starts to appear and by the end of embryonic development, the
three isoforms have about the same abundance. To investigate whether the factors
screened have a role in the splicing patterns of Ubx, RNA was extracted from three
independent samples of at least 50 homozygote embryos. RT-PCR was performed
using the primers previously used to assess the splicing of Ubx microexons by (Bur-
nette et al., 1999) that are designed in the 5’ exon and 3’ exon spanning the two
microexons (scheme in Figure 5.10A.).
In this experiment, RT-PCR of Ubx in selected mutants resulted in small vari-
ations relative to those seen with the wild type. This suggests that each factor
contributes modestly to the final output.
As a general trend, the results show a decrease in mI inclusion at the two devel-
opmental stages tested, suggesting a role of the factors for this process. Microexon I
inclusion at stage 15 is clearly reduced in the brahma mutant, and very little change
was seen in crn and fl(2)d mutants. The other genotypes do not show any signifi-
cant difference compared to the wild type control. mII inclusion at the same stage is
in general increased in all mutants tested, particularly in the Zn72D mutant, which
interestingly does not show an effect in mI inclusion. su(f) mutants also show the
same trend as zn72D ; no difference in mI exon inclusion but an increase in mII exon
inclusion (Figure 5.10). This suggests that these factors do not affect alternative
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splicing in general, but more likely work together with other factors present around
microexon II to modulate its splicing. Interestingly, at this stage brm appears to
affect only slightly the inclusion of microexon II, which is unexpected given its gen-
eral role in splicing. mi-2 shows a notable variation in the inclusion of microexon
II, which makes it difficult to interpret. However, there is a small increase of mII
inclusion, which contrasts with no difference in mI inclusion. mi-2 is a chromatin
remodelling factor and it has regulatory function in Ubx gene expression by making
the chromatin less accessible to transcription factors. For this reason, mi-2 was
expected to affect the inclusion of both exons in the same way so its differentially
effect in both Ubx microexons is unexpected. pasilla mutant shows a pattern very
similar to mi-2, no change in mI exon inclusion and a small increase in mII exon
inclusion (Figure 5.10).
Later in development at stage 17 (Figure 5.11), the role of the factors tested
seem different, and there is a general trend to a reduction on mI and mII inclusion,
leading to a slight increase in the production of II isoform. The brm, mi-2, zn72D
and hrb27c mutants show a reduction of mI inclusion, whereas the others show a
less marked effect. Interestingly, the brm mutant also slightly represses the inclusion
of the mII microexon, suggesting that it has a general effect in exon inclusion, in
agreement with previous studies in mammalian cells (Batsche´ et al., 2006). The crn
mutant shows the same effect on splicing as the brm mutant, also consistently with
its general role in the splicing machinery (Chung et al., 2002). However, we observe
that the splicing of the constitutive exons (5’ and 3’ exons) is not affected.
The mi-2 mutant shows a specific effect on mI inclusion, whereas mII seems not
to be affected. This effect seems contrary to the one observed at stage 15, where mI
inclusion was reduced the microexon affected in the mutant. The normal expression
of mi-2 at stage 15 is much higher than at stage 17, probably different levels of the
protein results in different regulatory effects.
pasilla shows a very similar pattern to mi-2, but with a less marked reduction in
mI inclusion, which is again contrary to the effect observed at stage 15. However, PS
normal levels change considerably between stage 15 and 17. In contrast, the zn72D
shows opposite effects in mI and II. Whereas it shows a reduction in mI inclusion,
it is the only factor that shows a slight increase in mII inclusion. This suggests that
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Figure 5.10: Ubx splicing patterns at stage 15: RT-PCR of three independent bio-
logical RNA samples. A) RT-PCR using oligos around the variable region showing
the production of isoforms Ia, IIa or IVa in wild type or mutants for the factors
tested. B) Quantification of the Ia and IIa bands intensities and represented as
proportion of Ia/IIa isoforms. C) Quantification of the Ia and IVa bands intensities
and represented as the proportion of Ia/IVa isoforms showing a reduction of Ia/IIa
ratio in brm mutant and an increase in Ia/IVa ratio in ps, zn72D, su(f) and crn .
Bars represent standard error and * p≤ 0.05, ** p≤ 0.01 of the t-test in respect to
the wild type.
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there may be a cis or trans factor around mII that is absent in mI context. fl(2)d,
su(f) and hrb27c show a very similar pattern between them, a reduction in mI exon
inclusion and a very mild reduction in mII inclusion. These data show that they
affect both exons the same way at this developmental stage. However, su(f) shows
a different trend that the one observed at earlier stages, where mII inclusion was
promoted in the mutant background (Figure 5.11).
5.2.6 Ubx polyadenylation patterns
Polyadenylation site use in Ubx also changes during embryonic development. At
early stages, the proximal site is prefered, generating a short 3’ UTR and the distal
site is used later in development, specifically in the developing CNS, resulting in
long 3’ UTR (O’Connor et al., 1988), (Kornfeld et al., 1989),(Thomsen et al., 2010).
To assess the role of our candidate factors in polyadenylation site selection, primers
complementary to the proximal region (Universal) or the distal region (Distal) were
used in semiquantitative RT-PCR (Figure 5.9). The two pair of primers used in
these experiments show different efficiency in the PCR reaction.
Preliminary results show little difference in the ratio of proximal to distal polyade-
lylation site selection in stage 15. crn, hrb27c and su(f) mutants show no difference
in PAS choice, whereas mutations in zn72D and fl(2)d show higher levels of distal
polyadenylation site use, generating longer 3’ UTR. su(f) was expected to have a
more significant effect on polyadenyation site selection however, at this stage, su(f)
does not show any significant difference in long 3’ UTR levels. In contrast, mi-2
shows a slight decrease in the use of the distal PAS, generating shorter 3’ UTRs
(Figure 5.12). The presence of more mRNA with a long 3 ’UTR in the fl(2)d mu-
tant could explain the reduction of general Ubx mRNA levels seen in Ubx Universal
RT-PCRs, as the distal portion of the UTR has been demonstrated to be involved
in miRNA downregulation (Thomsen et al., 2010).
However, at the later stage of development, polyadenylation patterns change and
the mutant for crn and su(f) show an increase in the use of the second polyadenyla-
tion site, generating more long 3’ UTR (Figure 5.13). The effect in the su(f) mutant
is consistent with its function as a member of the CstF (Benoit et al., 2002) in that
it is needed for the first step of the 3’ end formation reaction. However, the effect of
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Figure 5.11: Ubx splicing patterns at stage 17: RT-PCR of three independent bio-
logical RNA samples. A) RT-PCR using oligos around the variable region showing
the production of isoforms Ia, IIa or IVa in wild type or mutants for the factos
tested. B) Quantification of the Ia and IIa bands intensities and represented as the
ratio of Ia/IIa isoforms. C) Quantification of the Ia and IVa bands intensities and
represented as the ratio of Ia/IVa isoforms showing that all of the mutants show
a reduction in the Ia/IIa ratio and brm,ps, su(f), fl(2)d, crn and hrb27c show a
reduction in the Ia/IVa ratio. Bars represent standard error and * p≤ 0.05, ** p≤
0.01 of the t-test in respect to wild type.119
mut st15.png
Figure 5.12: Polyadenylation site choice at stage 15: RT-PCR of three independent
biological RNA samples. Primers designed complementary to the proximal region of
distal region of the 3’ UTR were used (see scheme). A) RT-PCR of Ubx Universal
or Distal regions as shown in the right scheme and rp49 as loading control. B)
Quantification of the bands intensities and represented as Ubx Distal/Ubx Universal
ratio, showing an increase in zn72D and fl(2)d mutants. Bars represent standard
error and * p≤ 0.05, ** p≤ 0.01 of the t-test in respect to the wild type.
120
the crn mutant is novel in that it has not been reported to have a role in polyadeny-
lation. Nova is known to plays an important role in alternative polyadenylation in
the mammalian brain (Licatalosi et al., 2008), so the mutant of the Drosophila ho-
mologue, pasilla was expected to show an impact in Ubx polyadenylation. However,
I did not observed any significant effect.
This results indicate that the Ubx 3’ end formation during Drosophila develop-
ment is a dynamic process that depends on different factors at different time points.
In line with these results, it has been documented that at later stages the production
of a long UTR is predominant, compared to earlier stages (Hilgers et al., 2011). The
presence of a long UTR allows a more strict control of the transport, translation and
decay of this transcript and that one possible mechanism is downregulation by mi-
cro RNAs (Thomsen et al., 2010), (Patraquim et al., 2011), (Szostak and Gebauer,
2013).
These data points at a differential regulation of cassette exon inclusion between
stages 15 and 17 (Figure 5.14). At stage 15, fewer factors have an impact in splicing
than at stage 17 where almost all of the factors tested show an effect. Another
interesting observation is that at stage 15 the factors act in opposite directions in
microexon I and II inclusion whereas at stage 17 the effect on both microexons is to
the same direction.
For polyadenylation decisions, the effect is to the same direction (factors repress
the use of the distal polyadenylation site) but the factors involved are not the same
at stage 15 and 17 (Figure 5.14).
5.2.7 Factors binding to Ubx probes in vivo-preliminary re-
sults
In the attempt to identify proteins bound to the Ubx RNA probes tested in this
chapter, UV crosslinks followed by RNAse protection assays were performed as
described in the Methods section using Nuclear Extracts form whole embryos at
late stages. Preliminary results show several protection bands of different sizes in
site 3 suggesting that there are several protein directly interacting with it in vivo
Figure 5.15). The size of the bands suggest that the Drosophila homolog of PTB,
haephesius, could be one of these factors (arrows in red in Figure 5.15). Further
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Figure 5.13: Polyadenylation site choice at stage 17: RT-PCR of three independent
biological RNA samples. A) RT-PCR of Ubx Universal or Distal regions as shown
in the right scheme and rp49 as loading control. B) Quantification of the bands
intensities and represented as Ubx Distal/Ubx Universal ratio showing an important
increase in crn and su(f) mutants. Bars represent standard error and * p≤ 0.05, **
p≤ 0.01 of the t-test in respect to the wild type.
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Figure 5.14: Schematic summary of the effects of the candidate factors in Ubx
splicing and polyadenylation. The effects observed at stage 15 are shown above the
scheme of the Ubx transcript and the ones observed at stage 17 are below. Arrow
pointing upwards represents exon inclusion, arrow pointing downwards represent
exon skiping. The asterisk marks the novel regulatory activities for the factor in
turn. 123
Figure 5.15: UV crosslink using Nuclear Extract reveal proteins binding to Ubx
probes. UV-crosslink were performed using recombinant Elav as a control and nu-
clear extracts as marked in source of protein. The RNA probe used is marked at
the bottom of the lanes. A no UV control was included and marked as - . Black
arrows mark the position of the Elav protein whereas red arrows mark the position
of possibly the PTB Drosophila homolog.
identification of the bands obtained is required.
5.3 Discussion
In this chapter I present preliminary data that suggests that a selection of protein
factors affect the RNA processing of Ubx during embryonic development. The fac-
tors tested had a modest contribution to the overall splicing and polyadenylation
output, and their contributions were not necessarily in the same direction at the
two developmental stages tested. Presumably, the factors tested will affect a large
spectrum of mRNA targets,leading to indirect effects in the regulation of Ubx tran-
scription or RNA processing. I confirmed the role of the factors tested and uncovered
new roles for some of them.
When the effect of the candidate proteins is observed globally, some interesting
patterns appear (Figure 5.14). At stage 15, fewer factors play a role in exon inclusion
and the effects are in contrary directions (exon skipping for mI and exon inclusion
for mII) whereas at stage 17, most of the mutant factors tested showed reduced
levels of exon inclusion. In other words, the protein factors tested act to stimulate
the inclusion of both cassette exons.
crn, fl(2)d and hrb27c played a role in Ubx mRNA splicing as expected. How-
124
ever, fl(2)d showed a less effect at the time points sampled whereas it was previously
shown to have an important role in larvae and adults. In my study, the two em-
bryonic stages tested showed different effect from the protein factors tested, making
evident the different roles they have along embryonic development (Figure 5.14).
hrb27c showed a clear effect in splicing at stage 17 but not at stage 15, which is
surprising given that it is a factor that regulates alternative splicing. In contrast,
hrb27c showed a marked effect in the overall levels of Ubx mRNA at the two time
points tested. The mechanism for this role is unknown. One possible explanation is
that it regulates the splicing of a key factor that affects the transcription of Ubx.
Javier Lopez and this study show that crn has a role the splicing of mI only,
at larval and adult stages. In this study, I observed the same effect observed in
the crn mutants by Javier Lopez lab at embryonic stages, which is to some extent,
surprising, given that crn has been described as a general alternative splicing factor,
so the same effect would be expected for both microexons. Interestingly, crn has
also a role in regulating Ubx mRNA levels, probably related to its also observed role
in polyadenylation site choice at stage 17. This is a very surprising result because a
role for crn in polyadenylation has not been reported and this could be a coupled
process between transcription, splicing and polyadenylation.
brahma showed a role in splicing of microexon I at stage 15, confirming previous
reports of brm role in splicing in other systems (Batsche´ et al., 2006). brahma
also showed a role in determining Ubx mRNA levels, probably related to its role
in transcription. However, brahma did not show any significant role in alternative
polyadenylation at the stages sampled. The attempt to map the brm2 mutant used
in this study showed a silent point mutation that does not explain the mutant
phenotype.
mi-2 also showed an effect on Ubx transcript abundance but in the opposite
direction at the two time points sampled. At stage 15, the result is as expected,
being a repressor of Ubx transcription, Ubx is up-regulated in the mi-2 mutant.
However, at stage 17, I observed a decrease in Ubx mRNA. I observed an effect on
splicing particularly of microexon I at stage 17. mi-2 did not show any significant
role in polyadenylation site choice at the stages sampled. pasilla has previously
demonstrated to play roles in splicing and polyadenylation but in this study I only
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observed an effect on splicing at stage 15. ps mutants also showed an effect on Ubx
transcript levels, role not previously described. This suggests that it either plays a
role in transcription regulation or mRNA stability, or the observations are the result
of an indirect effect.
The only polyadenylation factor tested, su(f) showed a considerable effect in
polyadenylation site choice at stage 17 as expected, but also showed an effect in
splicing at stage 15, a function not previously reported. My data showed a role
in Ubx transcript abundance but in the opposite direction as expected. su(f) is
involved in RNA decay so I would have expected the mutation to up-regulate Ubx
mRNA levels.
5.3.1 Splicing and polyadenylation relationship
Previous studies have found a correlation between splicing and polyadenylation pat-
terns in Ubx (O’Connor et al., 1988), (Kornfeld et al., 1989), (Thomsen et al., 2010)
where isoforms that have both microexons are proportionally more related to shorter
UTRs and isoforms without any microexons are more associated with longer UTRs.
These two processes could be controlled independently or they could be dependent
on one another. Looking for connections of these two processes in the mutants
tested, I observed that in the crn mutant, I do see a correlation; the mutant pro-
duces more isoform IV and produces also more ”long” UTR. In this case, crn could
link splicing and polyadenylation indirectly, or directly. This is the first evidence of
crn having a role in polyadenylation. Interestingly, the same pattern is seen with
su(f) and I observed the production of more isoform II lacking mI and a longer UTR.
su(f) role in splicing seems to be more specific to the mI, unlike crn that seems to
have a more general role in the inclusion of both exons. The other factors did not
show any consistent relationship between splicing and polyadenylation.
The genome of Drosophila melanogaster has many more predicted RNA bind-
ing proteins that could also play an important role in shaping the splicing and
polyadenylation landscape during development and Ubx in particular. The inter-
action between the factors tested also remains to be elucidated. Deciphering the
factors and mechanisms involved in the control of RNA processing during develop-
ment would shed light on the understanding on the establishment of the morphology
126
and function of organisms.
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Chapter 6
Discussion
The aim of this project was to contribute to the understanding of the molecular basis
of Ubx mRNA processing control during the embryonic development of Drosophila.
In this project I demonstrated that the Elav protein plays a role in splicing,
polyadenylation and total mRNA level of Ubx during embryonic development. I
also described two cis-elements within introns of Ubx that are able to interact di-
rectly with Elav in vitro. Other candidate factors were also tested for Ubx RNA
regulatory activity and most of them play modest roles in splicing and polyadeny-
lation patterning of Ubx. Interestingly, we did uncover some previously unknown
roles for some of the factors.
This study is focused on the late stages of Drosophila embryonic development
because is at this point when all the isoforms of Ubx are present, making it easier
to observe changes in the mRNA patterns produced. Elav protein also is expressed
at higher levels in later stages of development, making easier to measure the effects
of its mutation.
6.1 The role and mechanism of Elav in Ubx RNA
processing
In this project I demonstrated that Elav protein participates in the control of Ubx
splicing, promoting exon exclusion of both microexons. The data suggests that Elav
controls both microexons in the same direction. The precise mechanism for this role
is unclear. However, in in vitro binding assays, I demonstrate that Elav binds to an
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element (site 3) located 45 bp upstream of microexon I. This suggests the possibility
that Elav masks the downstream splicing site, promoting exon exclusion. This
mechanism is similar to the one described for the effect of Elav in polyadenylation,
interfering with the usage of the proximal PAS in erect wing (Soller and White,
2003). The other regulatory element bound by Elav (site 8) in vitro is downstream
of microexon II. This site is more than 8 kb away from the microexon II which makes
it less likely to play a role in splicing. However, considering the secondary structure
that RNA adopts and the factors that are bound to it while its being transcribed,
we cannot rule out the possibility that site 8 plays a role on microexon II splicing.
Site 13 did not show significant binding in the in vitro binding assays, however,
it is possible that a cofactor is needed for this interaction to occur in vivo. This
site is relatively close (3.5 kb) to a described resplicing site (RP3), which makes
it a candidate for resplicing control of the extraordinarily long third Intron of Ubx
(Burnette et al., 2005).
I also demonstrated that Elav plays a critical role in Ubx PAS choice, making
the transcript more visible to other regulatory factors such as miRNAs (Thomsen
et al., 2010). Experiments by other members of the lab have shown that ectopic
expression of Elav in earlier stages of embryonic development leads to a change in
polyadenylation choice site, observed by in situ hybridisation experiments (Rogulja-
Ortmann et al., 2014). The in vitro binding experiments did not show any significant
binding of Elav to the only site near the proximal PAS tested (site 16). This,
however, does not exclude its role in polyadenylation control in vivo. In other
systems, it has been suggested that the interaction of Elav with a target mRNA
is stabilised by ligands such as SETalpha, SETbeta, pp32, and APRIL (protein
phosphatase inhibitors) (Brennan et al., 2000). It is possible that in vivo, an Elav
ligand is required for the recognition and binding of the site 16, playing a role in
polyadenylation site choice. Supporting this idea, the sequence between the two
A/U sequences in site 16 contains a predicted PTB binding site.
The phenomenon of 3’ UTR lengthening as development progresses has been
observed in several transcripts within the developing CNS, where a more distal PAS
is used at a later point in development, producing transcripts with progressively
longer 3’ UTRs (Hilgers et al., 2011). The Levine group has demonstrated that Elav
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is responsible for such lengthening (Hilgers et al., 2012) in the embryonic CNS. It is
to note that they did not pick up Ubx in their study. Our work confirms the UTR
lenghtening in Ubx RNA although a putative binding site was not identified. The
work of Levine’s group show that the lengthening of brat, ago1, nej, pum and imp is
severely affected by the loss of Elav protein whereas the change in PAS use observed
in Ubx is less affected. Although in our study the effect might be contaminated by
non neuronal tissue, this also could point out to a more complex regulatory system
for Ubx polyadenylation during development, where the effect of Elav is mediated
by a third factor. Our work expands to the role of Elav on splicing along embryonic
development, demonstrating that Elav binds to Ubx RNA to regulate alternative
splicing. We also extended our study to the effect of polyadenylation site choice on
RNA levels and protein production. Our observation that total Ubx mRNA levels are
reduced in an elav mutant background was contrary to our expectations, where an
Ubx mRNA molecule containing a shorter 3’ UTR would be less visible to miRNAs,
so less down regulated (Thomsen et al., 2010). Modulation of Ubx protein levels
leads to changes in the apoptosis pattern of GW neuron in the posterior thoracic
and abdominal segments (Rogulja-Ortmann et al., 2014).
A possible explanation for this reduction is a ”stalling” of non-appropriately
spliced RNA molecule during transcription. Intronic in situ hybridisation exper-
iments carried out by Joao Osorio in the Alonso Lab showed an up regulation of
RNA associated to chromatin in elav mutant background compared to wild type late
embryos (Rogulja-Ortmann et al., 2014). This effect has already been described in
beta globin transcripts (Carmo-Fonseca et al., 1999).
Another possibility is that the Elav protein is promoting Ubx mRNA stabil-
ity, as demonstrated in mammalian systems (Hinman, M.N; Lou, 2008), (Ziegeler
et al., 2010), (Mukherjee et al., 2011), (Zhuang et al., 2013) so in its absence, Ubx
RNA degradation would increase. However, Elav promotes deadenylation and RNA
degradation in other systems, such as Xenopus Eg2 transcript (Legagneux et al.,
1992), and translation repression (Standart, 1993). The HuR protein also able to
interact with miRNAs to increase or reduce their activity on their targets (Kundu
et al., 2012) (and references therein). HuR in some cases prevents or dismantles the
miRISC complex from the mRNA (Kundu et al., 2012) and in other systems HuR
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is necessary for miRISC recruitment to the target mRNA (Kim et al., 2009). In
consequence, the interaction of Elav with the miRNA sites within the Ubx 3’ UTR
may play an important role for Ubx mRNA stability.
The Elav protein from Drosophila has important differences from its mammal
homologues: it has been only detected within the nucleus of neuronal tissue, whereas
the mammal proteins HuB/C and D are able to shuttle between the nucleus and cy-
toplasm in neuronal tissue (Colombrita et al., 2013). This allows the Hu proteins to
participate in cytoplasmic functions, like mRNA translation. For example, the HuD
mammal protein is capable of promoting mRNA circularisation in mammals, inter-
acting with eIF4A and the polyA, stimulating translation (Brennan et al., 2000).
The ubiquitously expressed HuR protein is able to control translation interacting
with internal ribosome entry site (IRES) (Rivas-Aravena et al., 2009). However, a
very close member of the Elav family, FNE, is mainly cytoplasmic, making it a pos-
sible candidate to carry on the cytoplasmic activities of the mammal counterparts.
6.2 Bio-informatic tools in the search of Elav bind-
ing sites
The efforts to elucidate a precise consensus sequence for Elav/HuR have been par-
tially succesful and have found that the protein is flexible to some extent in its
specificity requirements. A sequence rich in A/U is the common characteristic in
all the sites tested, from Drosophila (Haussmann et al., 2011) to Xenopus (Legag-
neux et al., 1992) and mammalian systems (Wang and Hall, 2001a), (Lo´pez de
Silanes et al., 2004). The minimal internal motif makes difficult to identify effec-
tively functional sites. Even within one of the most well characterised sites, within
the erect wing transcript, a comparison between the Drosophila melanogaster and
virilis sequence, reveals that the sequence elements is only partially conserved, but
the interaction with Elav remains the same (Haussmann et al., 2011).
Within the cell, the biochemical composition is different from the conditions in
the in vitro experiments described here, so it is likely that the secondary structure
of the RNAs within the cell, under physiological conditions would be different (Lai
et al., 2013), (Rouskin et al., 2013). Moreover, additional factors, such as RNA bind-
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ing proteins that are bound to the RNA molecule as it is transcribed might change
the secondary structure of the final transcript, probably modifying the structure
where the putative Elav binding sites lie, modifying their affinity to Elav and other
RNA binding proteins. There is evidence supporting this, suggesting that the RNA
starts folding as it is transcribed, following a determined folding pathway that will
dictate the final folding and in consequence, the function of the RNA (Lai et al.,
2013). One example of the role of protein in RNA folding is the folding of the yeast
mitochondrial group II intron ai5, aided by the protein cofactor Mss116 (Fedorova,
2014).
6.3 Other factors affecting Ubx RNA processing
In the experiments carried out to test the role of other factors in Ubx RNA process-
ing, the results suggest that each factor has a modest contribution to the overall
Ubx splicing and polyadenylation patterns. Moreover, their contributions were not
necessarily in the same direction at the two developmental stages tested. Presum-
ably, the factors tested will affect a large spectrum of targets, making possible that
those targets are available at different time points, that could in turn, affect Ubx
transcription or RNA processing.
Interestingly, I under covered new roles for some of the factors. For example, the
Crn factor that had been described as a splicing factor, in a crn mutant background,
the levels of Ubx are reduced. Crn also showed an effect on polyadenylation site
choice, role not described before. At stage 17, the levels of longer 3’ UTR in the crn
mutant background are increased very significatively, if compared to the wild type.
The effect is comparable with the one observed for the su(f) mutant, factor that
has a known role in polyadenylation. The Su(f) factor in turn, shows a significant
effect in splicing in my experiments. In a su(f) mutant background, mII inclusion
is promoted.
The chromatin remodelling factor, Mi-2 revealed a role in splicing, not described
before. The Mi-2 mutant shows an increase on mII inclusion, but no effect on mI.
The molecular basis for the effects observed are not known and its study will help
to further understand the cooperation of those factors to shape the RNA processing
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patterns during development.
6.4 Future work
The work presented here sets the start of a bigger project that aims to elucidate the
factors that shape the control of Ubx mRNA processing. The strategy used here
was useful but requires improvement. The bioinformatic search of Elav putative
binding sites can be improved adding a more detailed secondary structure analysis,
which has helped in other systems (Meisner et al., 2004), (Li et al., 2010). This
strategy could be also applied to search putative binding sites for the other candidate
factors demonstrated in this study to participate in Ubx mRNA processing, for their
posterior testing for direct interaction. A more sensitive technique such as Real Time
PCR can be used for the analysis of splicing and polyadenylation isoforms to improve
the quantifications and reduce the huge variation obtained by agarose gel-ethidium
bromide quantifications done in this study.
The RT-PCR experiments were carried out using RNA extracted from whole
embryos, in consequence, the tissue specific information was lost. It would be very
useful to study the mRNA processing of Ubx in isolated tissues, comparing neuronal
versus non neuronal context. We could then over express Elav in non neuronal tissues
and see if it is able to recapitulate the Ubx neuronal processing profile.
In our lab, a collection of Ubx ”minigenes” has been constructed by Dr. Stefan
Thomsen modifying the Ubx minigene produced by (Burnette et al., 2005) (Figure
6.1). The sequence of the introns of Ubx was shortened and cloned into constructs
that were injected into flies. The intronic sequences of the minigenes contains site
3, 5 and 16 sequences. If we express the minigenes in an elav null mutant, we can
test if the splicing and polyadenylation of the minigene is affected. We can also use
the minigene constructs to mutate the identified sites and test them in flies or in S2
cells and test if its processing is affected.
Another way of testing the sites, could be within a S2 cell system transfecting
a splicing construct and modulating Elav levels, and using RT-PCR to monitor the
splicing isoforms of Ubx produced. The constructs can also contain mutated versions
of the sites to test for changes in splicing activity.
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Figure 6.1: The Ubx minigene system. Top scheme represents the Ubx wt tran-
script, numbers show the sizes of the introns. HD, homeodomain. Below, modified
minigenes with shortened introns. The Homeodomain is substituted with two copies
of the HA (Haemaglutinin peptide) to allow the detection of the mRNA by PCR or
protein using an anti HA antibody. The positions of putative Elav binding sites are
marked with arrows. Mini Ubx short stops just after the proximal polyadenylation
site, the long minigene stops after the distal polyadenylation site whereas the third
construct has the proximal polyadenylation site deleted.
To test whether the sites identified to have binding activity in vivo, have any
role in splicing, in vitro splicing assays could be carried out using Elav protein
and a splicing construct containing the sites identified and test them against their
mutations (Ares, 2013). The role of the sites identified in polyadenylation can also
be addressed using in vitro systems, like the ones described in (Roca and Karginov,
2012).
ARE binding proteins have been described as factors that promote mRNA decay,
since deadenylation is frequently the first step in RNA decay (Standart, 1993), we
can test the polyadenylation status of each o the isoforms produced by Ubx in the
presence of absence of Elav or when the putative sites are mutated (Huang and
Richter, 2007).
Our data show that Elav protein produces RNA/protein complexes of different
sizes, suggesting the association of different number of Elav peptides in each com-
plex. We also observed that the number of intermediate complexes was different in
the RNA probes tested. In order to investigate the number of Elav peptides in each
complex, size exclusion chromatography experiments using the Elav/RNA reaction
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mixtures for EMSAS can be performed (Sahin and Roberts, 2012).
Elav could potentially use sites that we did not detect with the methods used
in this study, that could be identified by other approaches. Using whole embryo
lysates, UV-crosslink followed by immunoprecipitation using and anti-Elav antibody
and RNA sequencing could lead to the discovery of other sites that can be tested for
in vitro binding activity or for functional splicing or polyadenylation roles (Sugimoto
et al., 2012), (Anko¨ and Neugebauer, 2012). Modifications of the CLIP (Cross Link
Immuno Precipitation) approach have yielded good results in other systems (Singh
et al., 2013) and could be implemented here to identify Elav binding sites in vivo.
A possible strategy to search for candidate factors affecting Ubx mRNA process-
ing is UV-crosslink using Nuclear Extracts from whole embryos or tissue enriched
in neuronal cells (adult or larval heads) and labelled RNA from fragments of Ubx
(Walker et al., 1998). After RNAse digestion, a PAGE is run and the proteins
protecting the fragments can be identified by size or antibody staining. Alterna-
tively, RNA-IP using antibodies against Elav or the other candidate factors offer a
good strategy to identify RNA elements bound to this factors(Rodgers et al., 2002),
(Huber and Zhao, 2010),(Sibley et al., 2012).
To be able to identify other factors that are involved in Ubx mRNA processing,
another approach can be used, where sequences of the Ubx RNA are used to collect
and identify the proteins bound to it (Sibley et al., 2012). The proteins identified
then could be tested further for in vitro binding activity or in vivo assays to test
their precise role in RNA processing.
6.5 Final conclusions
The RNA processing of the Ubx gene is very dynamic during embryonic development
of Drosophila. The establishment of the appropriate patterns of RNA splicing and
polyadenylation isoforms is a crucial event for the correct functioning of the Ubx
gene. Several factors play a role in the establishment of such patterns and the
results of this project contribute to the identification of some of them. My data
also contributes to the understanding of the molecular mechanisms for the Elav
protein role in splicing by demonstrating a direct interaction between Elav and two
135
cis elements within Ubx introns.
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Appendix A
Chapter 1: Primers used
Name Sequence Position/use
UbxE1F tggaatgccaattgcaccatc 5’ Exon Ubx
Ubx.E3.ORF.R cctgcttctcctgttcgttc 3’ Exon Ubx
Ubx.short.F gaaatgacgcggagacagat proximal UTR
Ubx.E3.R-5 aatctgcgctccttccacta proximal UTR
Ubx.E3.F-4 gaacgaaggcagatgcaaat distal UTR
Ubx.E3.R-4 ggtaagtggtcggatgcagt distal UTR
Rp49L ccagtcggatcgatatgctaa RNA input
Rp49R tctgcatgagcaggacctc RNA input
ubx.E5.fw gccaccggaatggcaatggg Ubx levels
ubx.E5.rv agggactcatgcccagcgag Ubx levels
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Appendix B
Chapter 2: Primers used
Name Sequence
ewg.F atGGTACCattaatttttatttttaatt
ewg.R tatGTCGACagtataaaattataagataa
site3.F tatGGTACCcatatggtccaaacaccatcc
site3.R tatGTCGACaagcaaagcggagagaagaa
site5.F atGGTACCcccttagcctatagttttgcctat
site5.R tatGTCGACgcaacgcatatcgaataagtga
site8.F acatttatccccacgtcgtt
site 8.R tcagcgaaatgtgacagaaa
site13.F gcgaccactgcagaatgac
site13.R ccaacaaaagctgacagcag
site16.F atGGTACCGAAGATGTATACGTACTACCGCCTAA
site16.R tatGTCGACGACTCGATCCCCACATACATA
site3mut.F tgagagcaaacaattttgatttcacagtgtgtaaacgttttcttctctccgctttgc
site3mut.R gcaaagcggagagaagaaaacgtttacacactgtgaaatcaaaattgtttgctctca
site8Amut.F gcattatcagttaaaccaaatgtgtgtgtgtatcaaatttctgtcac
site8Amut.R gtgacagaaatttgatacacacacacatttggtttaactgataatgc
site8Bmut.F acatttatccccacgtcgttgctgtgtgtgttttaccctctccgg
site8Bmut.R ccggagagggtaaaacacacacagcaacgacgtggggataaatgt
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Appendix C
Chapter 2: Constructs used
Insert Vector Promoter
ewg pBluescript T7
ewg as pBluescript SP6
Site 3 pBluescript T7
Site 5 pGEMT T7
Site 8 pGEMT T7
Site 13 pGEMT SP6
Site 16 pBluescript T3
ewg pGEMT easy T7
ewg as pGEMT easy T7
Site 3 pGEMT easy T7
Site 8 pGEMT easy T7
Site 13 pGEMTeasy T7
Site 16 pGEMT easy T7
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Appendix D
Chapter 3: Primers used
Name Sequence
crn.F tctccatctcggcgtatttc
crn.R aggagcagcagcaggagat
suf.FW ctagtgtgaccgcagcgtaa
suf.R agcacaacgggcaaaataat
hrb27c.F cggtcacacagcattaaacg
hrb27c.R cggtcgcttttcgttcttac
fl(2)d.F gtcggttgggctcactttta
fl(2)d.R catgttggattgcgaacaa
PS.F cacacacacattcccgagtc
PS.R ctccgctctgctctctgg
mi-2.F gatcgattctctcccgactg
mi-2-R gtgaatgctggcaatgttgt
brm.F ccgttttgtgtgcctctttt
brm.R ttagcgtgcagttgatttcg
zn72d.F ctagtgtgaccgcagcgtaa
zn72d.R agcacaacgggcaaaataat
pz5p.rv tttgggagttttcaccaagg
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